Vitamin	B-protein
D	I-protein
receptor	I-protein
expression	O
in	O
human	B-cell_type
lymphocytes	I-cell_type
.	O

Signal	O
requirements	O
and	O
characterization	O
by	O
western	O
blots	O
and	O
DNA	O
sequencing	O
.	O

The	O
signals	O
controlling	O
the	O
expression	O
of	O
the	O
receptor	B-protein
protein	I-protein
for	O
1	O
alpha	O
,	O
25-dihydroxyvitamin	O
D3	O
in	O
normal	O
human	B-cell_type
lymphocytes	I-cell_type
and	O
the	O
relationship	O
of	O
this	O
protein	O
to	O
the	O
classical	B-protein
vitamin	I-protein
D	I-protein
receptor	I-protein
were	O
examined	O
.	O

Lymphocytes	B-cell_type
activated	O
with	O
the	O
OKT3	B-protein
antibody	I-protein
to	O
the	O
T-cell	B-protein
antigen	I-protein
receptor	I-protein
expressed	O
fewer	O
binding	O
sites	O
as	O
compared	O
to	O
lymphocytes	B-cell_type
that	O
were	O
activated	O
by	O
the	O
polyclonal	O
activator	O
phytohemagglutinin	B-protein
(	O
PHA	B-protein
)	O
.	O

However	O
,	O
combination	O
of	O
OKT3	B-protein
and	O
phorbol	O
myristate	O
acetate	O
produced	O
a	O
concentration	O
of	O
binding	O
sites	O
similar	O
to	O
the	O
PHA-activated	B-cell_line
cells	I-cell_line
.	O

The	O
receptor	O
from	O
OKT3	B-protein
and	O
OKT3	B-protein
+	O
phorbol	O
myristate	O
acetate	O
-activated	B-cell_type
lymphocytes	I-cell_type
exhibited	O
decreased	O
binding	O
to	O
DNA-cellulose	O
compared	O
to	O
PHA-activated	B-cell_type
lymphocytes	I-cell_type
.	O

In	O
lymphocytes	B-cell_type
activated	O
either	O
by	O
PHA	B-protein
or	O
OKT3	B-protein
(	O
but	O
not	O
in	O
resting	B-cell_type
cells	I-cell_type
)	O
,	O
a	O
50-kDa	B-protein
species	I-protein
cross-reacting	O
with	O
a	O
monoclonal	B-protein
antibody	I-protein
against	O
the	O
intestinal	B-protein
vitamin	I-protein
D	I-protein
receptor	I-protein
was	O
detected	O
.	O

Finally	O
,	O
RNA	O
from	O
activated	B-cell_type
lymphocytes	I-cell_type
was	O
amplified	O
by	O
polymerase	O
chain	O
reaction	O
using	O
oligonucleotide	O
primers	O
flanking	O
the	O
196	B-DNA
base	I-DNA
pair	I-DNA
long	I-DNA
region	I-DNA
encoding	O
the	O
DNA-binding	B-protein
domain	I-protein
of	O
the	O
human	B-protein
intestinal	I-protein
receptor	I-protein
.	O

The	O
amplified	O
product	O
showed	O
an	O
identical	B-DNA
nucleotide	I-DNA
sequence	I-DNA
to	O
the	O
DNA-binding	B-protein
domain	I-protein
of	O
the	O
human	B-protein
intestinal	I-protein
receptor	I-protein
.	O

These	O
findings	O
suggest	O
that	O
expression	O
of	O
the	O
1	B-protein
,	I-protein
25-	I-protein
(	I-protein
OH	I-protein
)	I-protein
2D3	I-protein
receptor	I-protein
in	O
lymphocytes	B-cell_type
is	O
triggered	O
by	O
distinct	O
and	O
contingent	O
signals	O
,	O
and	O
that	O
the	O
protein	O
and	O
the	O
mRNA	B-RNA
encoding	O
it	O
are	O
identical	O
to	O
the	O
classical	B-protein
vitamin	I-protein
D	I-protein
receptor	I-protein
.	O

THE	NULL
JOURNAL	NULL
or	NULL
B10LOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

266	NULL
,	NULL
No	NULL
.	NULL

12	NULL
,	NULL
Issue	NULL
of	NULL
April	NULL
25	NULL
,	NULL
pp	NULL
.	NULL

7588-7595	NULL
,	NULL
1991	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Vitamin	NULL
D	NULL
Receptor	NULL
Expression	NULL
in	NULL
Human	NULL
Lymphocytes	NULL
SIGNAL	NULL
REQUIREMENTS	NULL
AND	NULL
CHARACTERIZATION	NULL
BY	NULL
WESTERN	NULL
BLOTS	NULL
AND	NULL
DNA	NULL
SEQUENCING*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
November	NULL
19	NULL
,	NULL
1990	NULL
)	NULL
Xiao-Peng	NULL
Yu	NULL
,	NULL
Hanna	NULL
Mocharla	NULL
,	NULL
Frank	NULL
G.	NULL
Hustmyer	NULL
,	NULL
and	NULL
Stavros	NULL
C.	NULL
Manolagast	NULL
From	NULL
the	NULL
Section	NULL
of	NULL
Endocrinology	NULL
and	NULL
Metabolism	NULL
,	NULL
Veterans	NULL
Administration	NULL
Medical	NULL
Center	NULL
,	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Indiana	NULL
University	NULL
,	NULL
Indianapolis	NULL
,	NULL
Indiana	NULL
46202	NULL
The	NULL
signals	NULL
controlling	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
receptor	NULL
protein	NULL
for	NULL
1a,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
in	NULL
normal	NULL
human	NULL
lymphocytes	NULL
and	NULL
the	NULL
relationship	NULL
of	NULL
this	NULL
protein	NULL
to	NULL
the	NULL
classical	NULL
vitamin	NULL
D	NULL
receptor	NULL
were	NULL
examined	NULL
.	NULL

Lymphocytes	NULL
activated	NULL
with	NULL
the	NULL
OKT3	NULL
antibody	NULL
to	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
expressed	NULL
fewer	NULL
binding	NULL
sites	NULL
as	NULL
compared	NULL
to	NULL
lymphocytes	NULL
that	NULL
were	NULL
activated	NULL
by	NULL
the	NULL
polyclonal	NULL
activator	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
.	NULL

However	NULL
,	NULL
combination	NULL
of	NULL
OKT3	NULL
and	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
produced	NULL
a	NULL
concentration	NULL
of	NULL
binding	NULL
sites	NULL
similar	NULL
to	NULL
the	NULL
PHA-activated	NULL
cells	NULL
.	NULL

The	NULL
receptor	NULL
from	NULL
OKT3	NULL
and	NULL
OKT3	NULL
+	NULL
phorbol	NULL
myristate	NULL
acetate-activated	NULL
lymphocytes	NULL
exhibited	NULL
decreased	NULL
binding	NULL
to	NULL
DNA-cellulose	NULL
compared	NULL
to	NULL
PHA-activated	NULL
lymphocytes	NULL
.	NULL

In	NULL
lymphocytes	NULL
activated	NULL
either	NULL
by	NULL
PHA	NULL
or	NULL
OKT3	NULL
(	NULL
but	NULL
not	NULL
in	NULL
resting	NULL
cells	NULL
)	NULL
,	NULL
a	NULL
50-kDa	NULL
species	NULL
cross-reacting	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
against	NULL
the	NULL
intestinal	NULL
vitamin	NULL
D	NULL
receptor	NULL
was	NULL
detected	NULL
.	NULL

Finally	NULL
,	NULL
RNA	NULL
from	NULL
activated	NULL
lymphocytes	NULL
was	NULL
amplified	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
using	NULL
oligonucleotide	NULL
primers	NULL
flanking	NULL
the	NULL
196	NULL
base	NULL
pair	NULL
long	NULL
region	NULL
encoding	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
receptor	NULL
.	NULL

The	NULL
amplified	NULL
product	NULL
showed	NULL
an	NULL
identical	NULL
nucleotide	NULL
sequence	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
receptor	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
receptor	NULL
in	NULL
lymphocytes	NULL
is	NULL
triggered	NULL
by	NULL
distinct	NULL
and	NULL
contingent	NULL
signals	NULL
,	NULL
and	NULL
that	NULL
the	NULL
protein	NULL
and	NULL
the	NULL
mRNA	NULL
encoding	NULL
it	NULL
are	NULL
identical	NULL
to	NULL
the	NULL
classical	NULL
vitamin	NULL
D	NULL
receptor	NULL
.	NULL

During	NULL
the	NULL
last	NULL
few	NULL
years	NULL
it	NULL
has	NULL
been	NULL
established	NULL
that	NULL
the	NULL
hormonal	NULL
form	NULL
of	NULL
vitamin	NULL
Ds	NULL
,	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
(	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
)	NULL
,	NULL
'	NULL
has	NULL
a	NULL
much	NULL
wider	NULL
biologic	NULL
role	NULL
than	NULL
was	NULL
previously	NULL
thought	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
its	NULL
classical	NULL
role	NULL
in	NULL
mineral	NULL
and	NULL
skeletal	NULL
homeostasis	NULL
,	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
has	NULL
been	NULL
found	NULL
to	NULL
regulate	NULL
the	NULL
growth	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
function	NULL
of	NULL
a	NULL
broad	NULL
range	NULL
of	NULL
cells	NULL
,	NULL
including	NULL
lymphocytes	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

A	NULL
major	NULL
contribution	NULL
toward	NULL
the	NULL
appreciation	NULL
of	NULL
the	NULL
biologic	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
AI	NULL
21761	NULL
from	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Allergy	NULL
and	NULL
Immunology	NULL
and	NULL
by	NULL
the	NULL
Veterans	NULL
Adminis-tration	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

£	NULL
To	NULL
whom	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
ad-dressed	NULL
:	NULL
Section	NULL
of	NULL
Endocrinology/Metabolism	NULL
,	NULL
VA	NULL
Medical	NULL
Center	NULL
,	NULL
1481	NULL
W.	NULL
10th	NULL
St.	NULL
(	NULL
111E	NULL
)	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
46202	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
Ds	NULL
,	NULL
1	NULL
«	NULL
-25-dihydroxyvi-tamin	NULL
D	NULL
;	NULL
;	NULL
PHA	NULL
,	NULL
phytohemagglutinin	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
myristate	NULL
ace-tate	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
;	NULL
PBMC	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
BSA	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
;	NULL
Hepes	NULL
,	NULL
4-	NULL
(	NULL
2-hydroxyethyl	NULL
)	NULL
-l-piperazineeth-anesulfonic	NULL
acid	NULL
.	NULL

role	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
has	NULL
been	NULL
provided	NULL
by	NULL
the	NULL
elucidation	NULL
of	NULL
the	NULL
mechanism	NULL
of	NULL
its	NULL
action	NULL
.	NULL

In	NULL
the	NULL
classical	NULL
tissues	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
intestine	NULL
,	NULL
bone	NULL
,	NULL
kidney	NULL
)	NULL
,	NULL
the	NULL
hormonal	NULL
effects	NULL
are	NULL
mediated	NULL
via	NULL
specific	NULL
nuclear	NULL
receptors	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
complementary	NULL
DNA	NULL
clones	NULL
of	NULL
the	NULL
vitamin	NULL
D	NULL
receptor	NULL
gene	NULL
have	NULL
been	NULL
isolated	NULL
,	NULL
and	NULL
the	NULL
structures	NULL
of	NULL
the	NULL
gene	NULL
and	NULL
its	NULL
mRNA	NULL
have	NULL
been	NULL
determined	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
gene	NULL
belongs	NULL
to	NULL
the	NULL
same	NULL
family	NULL
of	NULL
genes	NULL
that	NULL
encode	NULL
the	NULL
receptors	NULL
for	NULL
the	NULL
other	NULL
steroid	NULL
hormones	NULL
and	NULL
shares	NULL
extensive	NULL
homologies	NULL
with	NULL
the	NULL
members	NULL
of	NULL
this	NULL
group	NULL
(	NULL
9	NULL
)	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
found	NULL
previously	NULL
that	NULL
cells	NULL
of	NULL
the	NULL
hematolymphopoietic	NULL
tissue	NULL
possess	NULL
a	NULL
receptor-like	NULL
binding	NULL
protein	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
10-12	NULL
)	NULL
.	NULL

In	NULL
monocytes	NULL
this	NULL
protein	NULL
is	NULL
expressed	NULL
constitutively	NULL
.	NULL

In	NULL
peripheral	NULL
blood	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
,	NULL
however	NULL
,	NULL
the	NULL
receptor-like	NULL
protein	NULL
is	NULL
expressed	NULL
upon	NULL
activation	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor-like	NULL
binding	NULL
,	NULL
is	NULL
also	NULL
found	NULL
in	NULL
vivo	NULL
(	NULL
ie	NULL
.	NULL

without	NULL
in	NULL
vitro	NULL
activation	NULL
)	NULL
in	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
of	NULL
rheumatoid	NULL
arthritis	NULL
patients	NULL
(	NULL
16	NULL
)	NULL
and	NULL
in	NULL
surgical	NULL
specimens	NULL
of	NULL
human	NULL
thymus	NULL
and	NULL
tonsils	NULL
(	NULL
17	NULL
)	NULL
.	NULL

In	NULL
both	NULL
these	NULL
tissues	NULL
,	NULL
a	NULL
positive	NULL
correlation	NULL
between	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
binding	NULL
and	NULL
the	NULL
activation	NULL
state	NULL
of	NULL
lymphocytes	NULL
has	NULL
been	NULL
found	NULL
.	NULL

Interestingly	NULL
enough	NULL
,	NULL
one	NULL
subset	NULL
of	NULL
T	NULL
lymphocytes	NULL
that	NULL
reside	NULL
in	NULL
the	NULL
thymus	NULL
express	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor-like	NULL
protein	NULL
constitutively	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

The	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
.D	NULL
;	NULL
receptor-bearing	NULL
cells	NULL
belong	NULL
to	NULL
the	NULL
peanut	NULL
agglutinin-negative	NULL
cell	NULL
population	NULL
that	NULL
is	NULL
localized	NULL
in	NULL
the	NULL
medulla	NULL
of	NULL
the	NULL
gland	NULL
and	NULL
exhibit	NULL
a	NULL
more	NULL
functionally	NULL
mature	NULL
phenotype	NULL
(	NULL
20	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
peanut	NULL
agglutinin-negative	NULL
cells	NULL
,	NULL
the	NULL
less	NULL
mature	NULL
peanut	NULL
agglutinin-positive	NULL
cells	NULL
that	NULL
are	NULL
localized	NULL
in	NULL
the	NULL
cortex	NULL
of	NULL
thymus	NULL
do	NULL
not	NULL
express	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
binding	NULL
.	NULL

From	NULL
these	NULL
observations	NULL
,	NULL
it	NULL
has	NULL
become	NULL
apparent	NULL
that	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
receptor-like	NULL
protein	NULL
of	NULL
normal	NULL
lymphocytes	NULL
is	NULL
highly	NULL
regulated	NULL
,	NULL
so	NULL
that	NULL
it	NULL
is	NULL
expressed	NULL
at	NULL
distinct	NULL
stages	NULL
of	NULL
maturation	NULL
and	NULL
upon	NULL
the	NULL
reception	NULL
of	NULL
external	NULL
signals	NULL
that	NULL
lead	NULL
lymphocytes	NULL
along	NULL
the	NULL
pathway	NULL
to	NULL
immune	NULL
function	NULL
.	NULL

It	NULL
is	NULL
not	NULL
known	NULL
,	NULL
however	NULL
,	NULL
how	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor-like	NULL
protein	NULL
is	NULL
regulated	NULL
in	NULL
lymphocytes	NULL
and	NULL
whether	NULL
this	NULL
protein	NULL
is	NULL
identical	NULL
or	NULL
different	NULL
from	NULL
the	NULL
one	NULL
that	NULL
is	NULL
expressed	NULL
constitutively	NULL
in	NULL
the	NULL
classical	NULL
target	NULL
tissues	NULL
of	NULL
the	NULL
hormone	NULL
.	NULL

By	NULL
using	NULL
agents	NULL
that	NULL
mediate	NULL
only	NULL
a	NULL
subset	NULL
of	NULL
intracellular	NULL
events	NULL
and	NULL
thus	NULL
an	NULL
incomplete	NULL
signal	NULL
of	NULL
lymphocyte	NULL
activation	NULL
,	NULL
earlier	NULL
studies	NULL
have	NULL
revealed	NULL
heterogeneous	NULL
patterns	NULL
of	NULL
gene	NULL
expression	NULL
indicating	NULL
that	NULL
a	NULL
multiplicity	NULL
of	NULL
signaling	NULL
pathways	NULL
extend	NULL
from	NULL
the	NULL
cell	NULL
surface	NULL
to	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
(	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

It	NULL
is	NULL
now	NULL
well	NULL
established	NULL
that	NULL
in	NULL
most	NULL
T-cells	NULL
at	NULL
least	NULL
two	NULL
signals	NULL
are	NULL
required	NULL
to	NULL
initiate	NULL
the	NULL
activation	NULL
process	NULL
,	NULL
one	NULL
supplied	NULL
by	NULL
the	NULL
T-cells	NULL
antigen	NULL
receptor	NULL
and	NULL
the	NULL
other	NULL
by	NULL
accessory	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
requirement	NULL
for	NULL
the	NULL
first	NULL
of	NULL
these	NULL
two	NULL
signals	NULL
can	NULL
be	NULL
met	NULL
in	NULL
part	NULL
by	NULL
lectins	NULL
or	NULL
antibodies	NULL
to	NULL
the	NULL
T-cell	NULL
receptor	NULL
complex	NULL
;	NULL
while	NULL
the	NULL
requirement	NULL
for	NULL
the	NULL
second	NULL
(	NULL
accessory	NULL
cells	NULL
and	NULL
their	NULL
products	NULL
)	NULL
can	NULL
be	NULL
mimicked	NULL
7588	NULL
The	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
Receptor	NULL
in	NULL
Human	NULL
Lymphocytes	NULL
by	NULL
agents	NULL
that	NULL
activate	NULL
protein	NULL
kinase	NULL
C.	NULL
The	NULL
different	NULL
signals	NULL
generated	NULL
upon	NULL
activation	NULL
of	NULL
lymphocytes	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
integrated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
the	NULL
responsive	NULL
genes	NULL
to	NULL
enhance	NULL
their	NULL
transcription	NULL
(	NULL
21	NULL
,	NULL
23	NULL
)	NULL
.	NULL

To	NULL
better	NULL
understand	NULL
the	NULL
mechanism	NULL
underlining	NULL
the	NULL
appearance	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor-like	NULL
binding	NULL
in	NULL
lymphocytes	NULL
following	NULL
activation	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
influence	NULL
of	NULL
distinct	NULL
intracellular	NULL
signaling	NULL
pathways	NULL
on	NULL
this	NULL
event	NULL
.	NULL

Specifi-cally	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
dissect	NULL
the	NULL
contributions	NULL
of	NULL
the	NULL
two	NULL
major	NULL
signaling	NULL
pathways	NULL
in	NULL
lymphocyte	NULL
activation	NULL
,	NULL
namely	NULL
,	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
and	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
signaling	NULL
pathways	NULL
.	NULL

The	NULL
influence	NULL
of	NULL
the	NULL
former	NULL
pathway	NULL
was	NULL
assessed	NULL
using	NULL
the	NULL
OKT3	NULL
monoclonal	NULL
antibody	NULL
which	NULL
recognizes	NULL
the	NULL
invariant	NULL
CD3	NULL
proteins	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
complex	NULL
,	NULL
while	NULL
the	NULL
influence	NULL
of	NULL
the	NULL
latter	NULL
pathway	NULL
was	NULL
examined	NULL
using	NULL
the	NULL
protein	NULL
kinase	NULL
activator	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
.	NULL

Results	NULL
from	NULL
cells	NULL
activated	NULL
with	NULL
the	NULL
above	NULL
stimuli	NULL
were	NULL
then	NULL
compared	NULL
to	NULL
results	NULL
obtained	NULL
from	NULL
lymphocytes	NULL
activated	NULL
by	NULL
PHA	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
trigger	NULL
both	NULL
the	NULL
T-cell	NULL
receptor	NULL
pathway	NULL
(	NULL
CD3	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
CD2	NULL
,	NULL
and	NULL
E	NULL
rosette	NULL
receptor	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
characterized	NULL
the	NULL
lymphocyte	NULL
receptor	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
by	NULL
means	NULL
of	NULL
Western	NULL
blots	NULL
and	NULL
partial	NULL
DNA	NULL
sequencing	NULL
.	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
,	NULL
similar	NULL
to	NULL
other	NULL
activation-induced	NULL
genes	NULL
in	NULL
lymphocytes	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
is	NULL
triggered	NULL
by	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
and	NULL
perhaps	NULL
contingent	NULL
signals	NULL
arising	NULL
from	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
and	NULL
the	NULL
protein	NULL
kinase	NULL
C-dependent	NULL
intracellular	NULL
pathway	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
they	NULL
establish	NULL
that	NULL
the	NULL
protein	NULL
and	NULL
the	NULL
mRNA	NULL
encoding	NULL
the	NULL
receptor	NULL
in	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
are	NULL
identical	NULL
to	NULL
those	NULL
encoded	NULL
by	NULL
the	NULL
gene	NULL
that	NULL
is	NULL
expressed	NULL
constitutively	NULL
in	NULL
the	NULL
classical	NULL
target	NULL
tissues	NULL
of	NULL
the	NULL
hormone	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
-	NULL
[	NULL
26,27-methyl-°H	NULL
]	NULL
D	NULL
;	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
158	NULL
Ci/mmo	NULL
!	NULL
)	NULL

,	NULL
{	NULL
methyl-*H	NULL
]	NULL
thymidine	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
5	NULL
Ci/mmol	NULL
)	NULL
,	NULL
and	NULL
radioiodinated	NULL
protein	NULL
A	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
30	NULL
mCi/mg	NULL
total	NULL
protein	NULL
A	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Amersham	NULL
Corp.	NULL
Crystalline	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr.	NULL
Milan	NULL
Uskokovic	NULL
(	NULL
Hoffmann-LaRoche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

PHA	NULL
,	NULL
PMA	NULL
,	NULL
and	NULL
affinity	NULL
isolated	NULL
rabbit	NULL
anti-rat	NULL
IgG	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Fetal	NULL
bovine	NULL
serum	NULL
was	NULL
purchased	NULL
from	NULL
Hyclone	NULL
Laboratories	NULL
Inc.	NULL
(	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
.	NULL

Antibiotics	NULL
and	NULL
L-glutamine	NULL
were	NULL
obtained	NULL
from	NULL
Irvine	NULL
Scientific	NULL
(	NULL
Santa	NULL
Ana	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Acrylamide	NULL
,	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
,	NULL
bisacrylamide	NULL
and	NULL
DEAE-cellulose	NULL
(	NULL
DE52	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Bio-Rad	NULL
,	NULL
DNA-cellulose	NULL
was	NULL
purchased	NULL
from	NULL
Worthington	NULL
Biochemical	NULL
Corp.	NULL
(	NULL
Freehold	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

Anti-leu-3a	NULL
(	NULL
CD4	NULL
)	NULL
and	NULL
anti-leu-2a	NULL
(	NULL
CD8	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Moun-tain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
OKT3	NULL
monoclonal	NULL
antibody	NULL
for	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
was	NULL
generated	NULL
from	NULL
hybridoma	NULL
cells	NULL
and	NULL
used	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1:250	NULL
.	NULL

The	NULL
antireceptor	NULL
monoclonal	NULL
antibody	NULL
(	NULL
9A77	NULL
)	NULL
(	NULL
26	NULL
)	NULL
and	NULL
enriched	NULL
preparation	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
from	NULL
transfected	NULL
COS	NULL
cells	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
Wesley	NULL
Pike	NULL
,	NULL
Baylor	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
Houston	NULL
,	NULL
TX	NULL
.	NULL

Quantitation	NULL
of	NULL
radioactivity	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
scintillation	NULL
mixture	NULL
Scintisol	NULL
(	NULL
ISOLAB	NULL
Inc.	NULL
,	NULL
Akron	NULL
,	NULL
OH	NULL
)	NULL
or	NULL
Betamax	NULL
(	NULL
ICN	NULL
Biomedicals	NULL
,	NULL
Inc.	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
in	NULL
a	NULL
Beckman	NULL
LS1801	NULL
instrument	NULL
.	NULL

Buffers-The	NULL
composition	NULL
of	NULL
the	NULL
buffers	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
is	NULL
as	NULL
follows	NULL
:	NULL
KETD	NULL
=	NULL
0.01	NULL
m	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
1.5	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
variable	NULL
molar	NULL
concentrations	NULL
of	NULL
KCl	NULL
as	NULL
indicated	NULL
,	NULL
eg	NULL
.	NULL

KETD-0.3	NULL
;	NULL
PBS	NULL
=	NULL
0.02	NULL
M	NULL
Na	NULL
;	NULL
HPo	NULL
,	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
0.15	NULL
M	NULL
NaCl	NULL
;	NULL
TBS	NULL
=	NULL
0.01	NULL
m	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
7.2	NULL
,	NULL
0.15	NULL
M	NULL
NaCl	NULL
.	NULL

Cell	NULL
Isolation	NULL
and	NULL
Culture-Peripheral	NULL
blood	NULL
was	NULL
obtained	NULL
from	NULL
normal	NULL
volunteers	NULL
from	NULL
either	NULL
sex	NULL
or	NULL
from	NULL
buffy	NULL
coats	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
regulations	NULL
of	NULL
the	NULL
Indiana	NULL
University	NULL
Review	NULL
Board	NULL
,	NULL
and	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
and	NULL
resuspended	NULL
(	NULL
1-2	NULL
x	NULL
10	NULL
%	NULL
/ml	NULL
)	NULL
in	NULL
RPMI-1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inacti-vated	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
antibiotics	NULL
(	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
,	NULL
100	NULL
units/ml	NULL
penicillin	NULL
)	NULL
,	NULL
and	NULL
25	NULL
mM	NULL
Hepes	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
incubated	NULL
in	NULL
plastic	NULL
culture	NULL
flasks	NULL
(	NULL
Falcon	NULL
,	NULL
Becton	NULL
Dick-inson	NULL
,	NULL
Oxnard	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
95	NULL
%	NULL
air	NULL
.	NULL

The	NULL
adherence	NULL
step	NULL
was	NULL
performed	NULL
in	NULL
order	NULL
to	NULL
eliminate	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
adherent	NULL
monocytes	NULL
,	NULL
which	NULL
are	NULL
known	NULL
to	NULL
possess	NULL
receptors	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
7589	NULL
(	NULL
16	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
the	NULL
nonadherent	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
counted	NULL
,	NULL
and	NULL
stimulated	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
,	NULL
OKT3	NULL
(	NULL
1:250	NULL
)	NULL
,	NULL
and	NULL
combination	NULL
of	NULL
OKT3	NULL
and	NULL
PMA	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
.	NULL

Cytosol	NULL
Preparations-At	NULL
the	NULL
end	NULL
of	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
RPMI	NULL
medium	NULL
(	NULL
without	NULL
serum	NULL
)	NULL
and	NULL
counted	NULL
.	NULL

Washed	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
KETD-0.3	NULL
and	NULL
sonicated	NULL
with	NULL
three	NULL
20-s	NULL
cycles	NULL
interrupted	NULL
by	NULL
60-s	NULL
pauses	NULL
(	NULL
Sonifer	NULL
cell	NULL
disrupter	NULL
,	NULL
Heat	NULL
Systems-Ultrasonics	NULL
,	NULL
Inc.	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

The	NULL
sonicate	NULL
was	NULL
centrifuged	NULL
for	NULL
1	NULL
h	NULL
at	NULL
105,000	NULL
x	NULL
g	NULL
in	NULL
a	NULL
L8-55	NULL
Beckman	NULL
ultracentrifuge	NULL
to	NULL
yield	NULL
a	NULL
supernatant	NULL
(	NULL
cytosol	NULL
)	NULL
fraction	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
modified	NULL
method	NULL
of	NULL
Lowry	NULL
(	NULL
28	NULL
)	NULL
using	NULL
crystalline	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
standard	NULL
.	NULL

Saturation	NULL
Analysis-Aliquots	NULL
(	NULL
0.1	NULL
ml	NULL
)	NULL
of	NULL
cytosol	NULL
from	NULL
activated	NULL
cells	NULL
(	NULL
1.6	NULL
mg	NULL
of	NULL
protein/ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°HJD	NULL
;	NULL
(	NULL
1	NULL
x	NULL
x	NULL
10~°	NULL
M	NULL
)	NULL
alone	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
200-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Bound	NULL
sterol	NULL
was	NULL
then	NULL
separated	NULL
from	NULL
free	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
ice-cold	NULL
Dextran-coated	NULL
charcoal	NULL
suspension	NULL
(	NULL
1.25	NULL
%	NULL
Norit	NULL
A	NULL
and	NULL
0.125	NULL
%	NULL
Dextran	NULL
T-70	NULL
)	NULL
in	NULL
0.1	NULL
%	NULL
gelatin	NULL
buffer	NULL
containing	NULL
0.1	NULL
M	NULL
NaH	NULL
;	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
0.039	NULL
M	NULL
Na	NULL
;	NULL
HPO	NULL
,	NULL
,	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
and	NULL
0.015	NULL
M	NULL
sodium	NULL
azide	NULL
.	NULL

The	NULL
specific	NULL
binding	NULL
(	NULL
total	NULL
minus	NULL
nonspecific	NULL
)	NULL
was	NULL
plotted	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Scatchard	NULL
.	NULL

Sucrose	NULL
Density	NULL
Sedimentation-Activated	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
medium	NULL
and	NULL
equal	NULL
number	NULL
from	NULL
the	NULL
different	NULL
stimulation	NULL
conditions	NULL
were	NULL
incubated	NULL
intact	NULL
with	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°H	NULL
]	NULL
JD	NULL
;	NULL
(	NULL
1	NULL
x	NULL
10~	NULL
M	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
200-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
hormone	NULL
.	NULL

Incubations	NULL
were	NULL
carried	NULL
out	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
followed	NULL
by	NULL
10	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
intact	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
saline	NULL
supplemented	NULL
with	NULL
0.2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

Cytosols	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
above	NULL
and	NULL
were	NULL
layered	NULL
onto	NULL
4-24	NULL
%	NULL
sucrose	NULL
density	NULL
gradients	NULL
prepared	NULL
by	NULL
layering	NULL
0.65	NULL
ml	NULL
each	NULL
of	NULL
24	NULL
,	NULL
20	NULL
,	NULL
16	NULL
,	NULL
12	NULL
,	NULL
8	NULL
,	NULL
and	NULL
4	NULL
%	NULL
sucrose	NULL
in	NULL
KETD-0.3	NULL
into	NULL
polyalcohol	NULL
tubes	NULL
(	NULL
Beckman	NULL
)	NULL
.	NULL

The	NULL
gradients	NULL
were	NULL
centrifuged	NULL
for	NULL
19	NULL
h	NULL
at	NULL
135,000	NULL
x	NULL
g.	NULL
Fractions	NULL
(	NULL
20	NULL
xX	NULL
0.2	NULL
ml	NULL
)	NULL
were	NULL
collected	NULL
with	NULL
a	NULL
Beckman	NULL
Fraction	NULL
Recovery	NULL
System	NULL
and	NULL
aliquots	NULL
were	NULL
counted	NULL
for	NULL
radioactivity	NULL
.	NULL

Chymotrypsinogen	NULL
(	NULL
S	NULL
=	NULL
2.55	NULL
)	NULL
and	NULL
ovalbumin	NULL
(	NULL
S8	NULL
=	NULL
3.75	NULL
)	NULL
were	NULL
used	NULL
as	NULL
sedimentation	NULL
coefficient	NULL
standards	NULL
.	NULL

DNA-Cellulose	NULL
and	NULL
DEAE-Cellulose	NULL
Chromatography-Cells	NULL
were	NULL
incubated	NULL
intact	NULL
with	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°H	NULL
]	NULL
D	NULL
;	NULL
(	NULL
2	NULL
x	NULL
10~°	NULL
M	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cytosol	NULL
fraction	NULL
was	NULL
precipitated	NULL
with	NULL
ammonium	NULL
sulfate	NULL
(	NULL
40	NULL
%	NULL
of	NULL
saturation	NULL
)	NULL
.	NULL

Resolubilized	NULL
cytosol	NULL
in	NULL
KETD-O0	NULL
was	NULL
applied	NULL
to	NULL
15-ml	NULL
columns	NULL
prepacked	NULL
with	NULL
either	NULL
DNA-cellulose	NULL
or	NULL
DEAE-cellulose	NULL
and	NULL
then	NULL
eluted	NULL
with	NULL
90-ml	NULL
of	NULL
linear	NULL
KCI	NULL
gradient	NULL
(	NULL
0.15-0.6	NULL
M	NULL
KCl	NULL
for	NULL
the	NULL
DNA-cellulose	NULL
or	NULL
0-0.6	NULL
M	NULL
KCl	NULL
for	NULL
the	NULL
DEAE-cellulose	NULL
)	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
.	NULL

Fractions	NULL
(	NULL
3	NULL
ml	NULL
)	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
aliquots	NULL
were	NULL
counted	NULL
for	NULL
tritium	NULL
.	NULL

Salt	NULL
concentration	NULL
was	NULL
monitored	NULL
by	NULL
conductivity	NULL
measurements	NULL
.	NULL

Assessment	NULL
of	NULL
Cell	NULL
Proliferation-Triplicate	NULL
aliquots	NULL
(	NULL
0.2	NULL
x	NULL
10°	NULL
cells/0.2	NULL
ml	NULL
medium	NULL
)	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
flat	NULL
bottom	NULL
96-well	NULL
plates	NULL
and	NULL
pulsed	NULL
for	NULL
19	NULL
h	NULL
with	NULL
[	NULL
°H	NULL
)	NULL
thymidine	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
on	NULL
glass	NULL
fiber	NULL
filter	NULL
using	NULL
an	NULL
automated	NULL
harvester	NULL
(	NULL
Skatron	NULL
,	NULL
Inc.	NULL
Sterling	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
then	NULL
air	NULL
dried	NULL
,	NULL
transferred	NULL
to	NULL
scintillation	NULL
vials	NULL
,	NULL
and	NULL
counted	NULL
.	NULL

Flow	NULL
Cytometric	NULL
Analysis	NULL
of	NULL
PBMC	NULL
Surface	NULL
Markers-At	NULL
the	NULL
end	NULL
of	NULL
72	NULL
h	NULL
of	NULL
incubation	NULL
,	NULL
PBMC	NULL
were	NULL
collected	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
counted	NULL
.	NULL

Resting	NULL
,	NULL
PHA-activated	NULL
and	NULL
OKT3-activated	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
sodium	NULL
azide	NULL
and	NULL
1	NULL
%	NULL
BSA	NULL
and	NULL
stained	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
CD4	NULL
and	NULL
CD8	NULL
directly	NULL
conjugated	NULL
with	NULL
fluorescein	NULL
and	NULL
phycoerythrin	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Stained	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
fixed	NULL
in	NULL
1.0	NULL
ml	NULL
of	NULL
PBS	NULL
with	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
Coulter	NULL
Epics	NULL
Profile	NULL
II	NULL
flow	NULL
cytometer	NULL
with	NULL
a	NULL
25	NULL
milliwatt	NULL
air-cooled	NULL
argon	NULL
laser	NULL
filtered	NULL
optimally	NULL
to	NULL
detect	NULL
phycoerythrin	NULL
and	NULL
fluorescein	NULL
fluorescence	NULL
.	NULL

Through	NULL
the	NULL
use	NULL
of	NULL
KC56	NULL
(	NULL
CD	NULL
45-pan	NULL
lymphoid	NULL
marker	NULL
)	NULL
we	NULL
were	NULL
able	NULL
to	NULL
determine	NULL
the	NULL
purity	NULL
of	NULL
the	NULL
gated	NULL
population	NULL
.	NULL

When	NULL
the	NULL
value	NULL
of	NULL
KC56	NULL
was	NULL
below	NULL
95	NULL
%	NULL
(	NULL
less	NULL
than	NULL
95	NULL
%	NULL
lymphoid	NULL
positive	NULL
)	NULL
,	NULL
normalization	NULL
was	NULL
performed	NULL
.	NULL

This	NULL
provided	NULL
a	NULL
more	NULL
accurate	NULL
percentage	NULL
of	NULL
lymphocyte	NULL
positive	NULL
cells	NULL
for	NULL
a	NULL
given	NULL
surface	NULL
marker	NULL
.	NULL

Immunologic	NULL
Detection	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
Receptors-Crude	NULL
lymphocyte	NULL
cytosols	NULL
and	NULL
enriched	NULL
preparations	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
receptor	NULL
were	NULL
electrophoresed	NULL
on	NULL
7.5	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gels	NULL
and	NULL
then	NULL
electrophoretically	NULL
transferred	NULL
from	NULL
the	NULL
gel	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
using	NULL
a	NULL
TE42	NULL
Transphor	NULL
apparatus	NULL
(	NULL
Hoefer	NULL
Scientific	NULL
Instruments	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Complete	NULL
transfer	NULL
of	NULL
all	NULL
proteins	NULL
was	NULL
achieved	NULL
at	NULL
3.5	NULL
h	NULL
at	NULL
20	NULL
V.	NULL
Upon	NULL
completion	NULL
of	NULL
the	NULL
transfer	NULL
,	NULL
the	NULL
nitrocellulose	NULL
membranes	NULL
were	NULL
subject	NULL
to	NULL
immunoblot	NULL
analysis	NULL
as	NULL
follows	NULL
.	NULL

Membranes	NULL
were	NULL
incubated	NULL
with	NULL
PBS	NULL
containing	NULL
3	NULL
%	NULL
BSA	NULL
,	NULL
for	NULL
2-4	NULL
h	NULL
at	NULL
22°C	NULL
and	NULL
then	NULL
transferred	NULL
to	NULL
PBS	NULL
7590	NULL
containing	NULL
1	NULL
%	NULL
BSA	NULL
,	NULL
2	NULL
ug/ml	NULL
9A77	NULL
antibody	NULL
,	NULL
and	NULL
were	NULL
shaken	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Washing	NULL
was	NULL
achieved	NULL
by	NULL
gently	NULL
shaking	NULL
the	NULL
membranes	NULL
for	NULL
25	NULL
min	NULL
at	NULL
22	NULL
°C	NULL
in	NULL
100	NULL
ml	NULL
of	NULL
TBS	NULL
containing	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
;	NULL
this	NULL
step	NULL
was	NULL
repeated	NULL
four	NULL
times	NULL
.	NULL

Following	NULL
a	NULL
2-4-h	NULL
preincu-bation	NULL
in	NULL
PBS	NULL
,	NULL
3	NULL
%	NULL
BSA	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
reincubated	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
in	NULL
PBS	NULL
,	NULL
1	NULL
%	NULL
BSA	NULL
containing	NULL
the	NULL
secondary	NULL
antibody	NULL
(	NULL
rabbit	NULL
anti-rat	NULL
IgG	NULL
,	NULL
1:2,000	NULL
dilution	NULL
of	NULL
1	NULL
mg/ml	NULL
)	NULL
.	NULL

The	NULL
nitrocellulose	NULL
was	NULL
then	NULL
rewashed	NULL
as	NULL
described	NULL
above	NULL
,	NULL
preincubated	NULL
in	NULL
PBS	NULL
,	NULL
0.3	NULL
%	NULL
BSA	NULL
for	NULL
2-4	NULL
h	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
radioiodinated	NULL
protein	NULL
A	NULL
in	NULL
PBS	NULL
,	NULL
1	NULL
%	NULL
BSA	NULL
for	NULL
3	NULL
h	NULL
at	NULL
22	NULL
°C	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
dried	NULL
and	NULL
then	NULL
autoradiographed	NULL
at	NULL
~70	NULL
°C	NULL
on	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
film	NULL
for	NULL
the	NULL
indicated	NULL
time	NULL
periods	NULL
.	NULL

PCR	NULL
Amplification	NULL
and	NULL
Sequencing-Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
PHA-	NULL
or	NULL
OKT3-stimulated	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
for	NULL
24	NULL
h	NULL
,	NULL
using	NULL
the	NULL
guanidinium-isothiocyanate	NULL
method	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Specific	NULL
oligonucleotide	NULL
primers	NULL
for	NULL
reverse	NULL
transcription	NULL
polymerase	NULL
chain	NULL
reaction	NULL
and	NULL
sequencing	NULL
were	NULL
designed	NULL
from	NULL
the	NULL
published	NULL
cDNA	NULL
sequence	NULL
of	NULL
human	NULL
intestinal	NULL
receptor	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Primers	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
DNA	NULL
synthesizer	NULL
model	NULL
381A	NULL
.	NULL

The	NULL
reverse	NULL
primer	NULL
A	NULL
5CTTGACCGGAACGTGCCCCGGATC3	NULL
'	NULL
(	NULL
bp	NULL
47-69	NULL
)	NULL
and	NULL
the	NULL
forward	NULL
primer	NULL
B	NULL
55CCTCATCTGTCAGAATG-AACTCC3	NULL
'	NULL
(	NULL
bp	NULL
295-273	NULL
)	NULL
used	NULL
for	NULL
reverse	NULL
transcription	NULL
polymerase	NULL
chain	NULL
reaction	NULL
were	NULL
framing	NULL
the	NULL
196	NULL
bp	NULL
long	NULL
region	NULL
encoding	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
classical	NULL
vitamin	NULL
D	NULL
receptor	NULL
.	NULL

Primers	NULL
C	NULL
5'ACCTGCCCCTTCAACGG3	NULL
'	NULL
(	NULL
bp	NULL
175-191	NULL
)	NULL
and	NULL
D	NULL
5¢CGGTTGTC-CTTGGTGAT3	NULL
'	NULL
(	NULL
bp	NULL
218-202	NULL
)	NULL
were	NULL
used	NULL
for	NULL
sequencing	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
2-5	NULL
ug	NULL
)	NULL
was	NULL
reverse	NULL
transcribed	NULL
with	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Bethesda	NULL
Research	NULL
Laborato-ries	NULL
)	NULL
and	NULL
primer	NULL
B	NULL
.	NULL

Reverse	NULL
transcribed	NULL
RNA	NULL
(	NULL
cDNA	NULL
)	NULL
was	NULL
amplified	NULL
with	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Cetus	NULL
)	NULL
,	NULL
and	NULL
gene-specific	NULL
primers	NULL
A	NULL
and	NULL
B	NULL
during	NULL
35	NULL
cycles	NULL
on	NULL
a	NULL
Perkin-Elmer	NULL
Cetus	NULL
PCR	NULL
DNA	NULL
Thermocycler	NULL
.	NULL

Each	NULL
cycle	NULL
consisted	NULL
of	NULL
denaturation	NULL
at	NULL
94	NULL
°C	NULL
for	NULL
2	NULL
min	NULL
,	NULL
annealing	NULL
at	NULL
60	NULL
°C	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72	NULL
°C	NULL
for	NULL
1.5	NULL
min	NULL
.	NULL

Reaction	NULL
mixture	NULL
contained	NULL
:	NULL
1	NULL
x	NULL
PCR	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
;	NULL
,	NULL
and	NULL
0.01	NULL
%	NULL
gelatin	NULL
)	NULL
,	NULL
dNTPs	NULL
(	NULL
200	NULL
um	NULL
of	NULL
each	NULL
)	NULL
,	NULL
600	NULL
ng	NULL
of	NULL
each	NULL
primer	NULL
,	NULL
and	NULL
2.5	NULL
units	NULL
of	NULL
AmpliTaq	NULL
DNA	NULL
polymerase	NULL
.	NULL

Amplified	NULL
DNA	NULL
was	NULL
extracted	NULL
with	NULL
phenol	NULL
and	NULL
chloroform	NULL
,	NULL
and	NULL
then	NULL
precipitated	NULL
with	NULL
95	NULL
%	NULL
ethanol	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
fractionated	NULL
on	NULL
4	NULL
%	NULL
Nu-Sieve	NULL
low	NULL
melting	NULL
temperature	NULL
agarose	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
band	NULL
was	NULL
ex-tracted	NULL
.	NULL

DNA	NULL
was	NULL
released	NULL
from	NULL
agarose	NULL
by	NULL
incubation	NULL
at	NULL
65	NULL
°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

For	NULL
asymmetric	NULL
PCR	NULL
500	NULL
ng	NULL
of	NULL
one	NULL
primer	NULL
,	NULL
10	NULL
ng	NULL
of	NULL
the	NULL
other	NULL
primer	NULL
,	NULL
and	NULL
5-10	NULL
ng	NULL
of	NULL
the	NULL
amplified	NULL
DNA	NULL
were	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
.	NULL

Reaction	NULL
mixture	NULL
and	NULL
amplification	NULL
condition	NULL
were	NULL
the	NULL
same	NULL
as	NULL
described	NULL
above	NULL
for	NULL
symmetric	NULL
PCR	NULL
.	NULL

Amplified	NULL
DNA	NULL
was	NULL
extracted	NULL
with	NULL
phenol	NULL
and	NULL
chloroform	NULL
and	NULL
then	NULL
spin	NULL
dialyzed	NULL
using	NULL
Centricon-30	NULL
(	NULL
Amicon	NULL
)	NULL
.	NULL

Amplified	NULL
single-stranded	NULL
DNA	NULL
was	NULL
sequenced	NULL
by	NULL
the	NULL
chain-termination	NULL
method	NULL
using	NULL
2',3'-dideoxynucleoside	NULL
5'-triphosphates	NULL
(	NULL
ddNTPs	NULL
)	NULL
as	NULL
inhibitors	NULL
(	NULL
30	NULL
)	NULL
and	NULL
Sequenase	NULL
(	NULL
Sequenase	NULL
,	NULL
version	NULL
2	NULL
,	NULL
United	NULL
States	NULL
Biochemical	NULL
Corp.	NULL
)	NULL
.	NULL

RESULTS	NULL
Effects	NULL
of	NULL
Distinct	NULL
Activation	NULL
Signals	NULL
on	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
ffFH	NULL
]	NULL
Ds	NULL
:	NULL
Binding	NULL
in	NULL
Lymphocytes-Comparison	NULL
of	NULL
sucrose	NULL
density	NULL
gradient	NULL
sedimentation	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°H	NULL
]	NULL
D	NULL
;	NULL
binding	NULL
in	NULL
lymphocytes	NULL
activated	NULL
either	NULL
with	NULL
PHA	NULL
or	NULL
OKT3	NULL
from	NULL
three	NULL
different	NULL
normal	NULL
donors	NULL
is	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

For	NULL
each	NULL
preparation	NULL
,	NULL
cells	NULL
were	NULL
divided	NULL
into	NULL
2	NULL
aliquots	NULL
and	NULL
incubated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
either	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
or	NULL
OKT3	NULL
(	NULL
1/250	NULL
dilution	NULL
)	NULL
.	NULL

In	NULL
all	NULL
three	NULL
samples	NULL
,	NULL
we	NULL
detected	NULL
a	NULL
singlké	NULL
displaceable	NULL
binding	NULL
peak	NULL
with	NULL
a	NULL
sedimentation	NULL
coefficient	NULL
of	NULL
3.3	NULL
s	NULL
,	NULL
indicating	NULL
that	NULL
at	NULL
least	NULL
by	NULL
this	NULL
criterion	NULL
,	NULL
the	NULL
binding	NULL
proteins	NULL
were	NULL
identical	NULL
in	NULL
the	NULL
two	NULL
activation	NULL
systems	NULL
.	NULL

However	NULL
,	NULL
the	NULL
height	NULL
of	NULL
the	NULL
radioactive	NULL
peak	NULL
and	NULL
the	NULL
area	NULL
under	NULL
the	NULL
peak	NULL
was	NULL
considerably	NULL
less	NULL
in	NULL
the	NULL
OKT	NULL
#	NULL
-activated	NULL
cells	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
PHA-activated	NULL
cells	NULL
.	NULL

This	NULL
finding	NULL
was	NULL
reproduced	NULL
in	NULL
all	NULL
15	NULL
samples	NULL
from	NULL
normal	NULL
donors	NULL
we	NULL
examined	NULL
.	NULL

The	NULL
lower	NULL
binding	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
OKT3-activated	NULL
lymphocytes	NULL
as	NULL
compared	NULL
to	NULL
PHA-activated	NULL
lymphocytes	NULL
,	NULL
seen	NULL
in	NULL
the	NULL
sucrose	NULL
gradients	NULL
,	NULL
was	NULL
due	NULL
to	NULL
a	NULL
difference	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
binding	NULL
studies	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
results	NULL
of	NULL
the	NULL
experiment	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Indeed	NULL
,	NULL
Scatchard	NULL
analysis	NULL
of	NULL
the	NULL
binding	NULL
in	NULL
cytosol	NULL
preparations	NULL
from	NULL
either	NULL
activa-	NULL
The	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
Ds3	NULL
Receptor	NULL
in	NULL
Human	NULL
Lymphocytes	NULL
tion	NULL
system	NULL
demonstrated	NULL
that	NULL
the	NULL
OKT3-induced	NULL
activation	NULL
led	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
fewer	NULL
binding	NULL
sites	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
PHA-induced	NULL
activation	NULL
.	NULL

The	NULL
affinity	NULL
of	NULL
the	NULL
binding	NULL
proteins	NULL
for	NULL
the	NULL
ligand	NULL
(	NULL
k	NULL
,	NULL
)	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
was	NULL
indistinguishable	NULL
between	NULL
the	NULL
two	NULL
activation	NULL
systems	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
could	NULL
be	NULL
due	NULL
to	NULL
a	NULL
different	NULL
time	NULL
course	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
[	NULL
°H	NULL
]	NULL
D	NULL
;	NULL
-binding	NULL
protein	NULL
in	NULL
cells	NULL
activated	NULL
by	NULL
the	NULL
two	NULL
different	NULL
agents	NULL
,	NULL
binding	NULL
was	NULL
determined	NULL
at	NULL
different	NULL
time	NULL
points	NULL
following	NULL
exposure	NULL
of	NULL
the	NULL
PBMC	NULL
to	NULL
the	NULL
two	NULL
activation	NULL
stimuli	NULL
.	NULL

In	NULL
both	NULL
systems	NULL
,	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
[	NULL
}	NULL
H	NULL
]	NULL
D	NULL
;	NULL
binding	NULL
was	NULL
maximal	NULL
at	NULL
48	NULL
h	NULL
and	NULL
declined	NULL
thereafter	NULL
.	NULL

At	NULL
each	NULL
time	NULL
point	NULL
,	NULL
however	NULL
,	NULL
OKT3-activated	NULL
cells	NULL
exhibited	NULL
lower	NULL
binding	NULL
than	NULL
the	NULL
PHA	NULL
-activated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
,	NULL
In	NULL
all	NULL
the	NULL
above	NULL
experiments	NULL
,	NULL
the	NULL
differences	NULL
in	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
[	NULL
°HIJDs	NULL
binding	NULL
could	NULL
not	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
differences	NULL
in	NULL
the	NULL
degree	NULL
of	NULL
activation	NULL
induced	NULL
by	NULL
the	NULL
different	NULL
stimuli	NULL
since	NULL
the	NULL
rate	NULL
of	NULL
DNA	NULL
synthesis	NULL
was	NULL
comparable	NULL
.	NULL

And	NULL
,	NULL
even	NULL
when	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°H	NULL
]	NULL
D	NULL
;	NULL
binding	NULL
was	NULL
corrected	NULL
per	NULL
rate	NULL
of	NULL
DNA	NULL
synthesis	NULL
only	NULL
a	NULL
fraction	NULL
(	NULL
30-60	NULL
%	NULL
)	NULL
of	NULL
the	NULL
binding	NULL
seen	NULL
with	NULL
PHA	NULL
could	NULL
be	NULL
elicited	NULL
by	NULL
the	NULL
OKT3	NULL
monoclonal	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
an	NULL
association	NULL
between	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-binding	NULL
sites	NULL
and	NULL
the	NULL
rate	NULL
of	NULL
DNA	NULL
synthesis	NULL
was	NULL
most	NULL
convincingly	NULL
demonstrated	NULL
,	NULL
however	NULL
,	NULL
in	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
the	NULL
inset	NULL
of	NULL
this	NULL
figure	NULL
in	NULL
the	NULL
PHA-activated	NULL
cells	NULL
,	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
incorporation	NULL
was	NULL
similar	NULL
at	NULL
48	NULL
,	NULL
72	NULL
,	NULL
and	NULL
96	NULL
h	NULL
following	NULL
exposure	NULL
of	NULL
the	NULL
cells	NULL
to	NULL
the	NULL
activation	NULL
agent	NULL
,	NULL
while	NULL
in	NULL
OKT3-activated	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
a	NULL
progressive	NULL
increase	NULL
in	NULL
[	NULL
*H	NULL
]	NULL
thy-midine	NULL
incorporation	NULL
with	NULL
time	NULL
following	NULL
activation	NULL
.	NULL

These	NULL
rates	NULL
of	NULL
DNA	NULL
synthesis	NULL
,	NULL
however	NULL
,	NULL
were	NULL
completely	NULL
dissociated	NULL
from	NULL
the	NULL
changes	NULL
in	NULL
the	NULL
apparent	NULL
concentration	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
signal-dependent	NULL
differences	NULL
in	NULL
the	NULL
number	NULL
of	NULL
binding	NULL
sites	NULL
could	NULL
not	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
differences	NULL
in	NULL
the	NULL
cell	NULL
types	NULL
present	NULL
in	NULL
the	NULL
cultures	NULL
following	NULL
stimulation	NULL
with	NULL
the	NULL
particular	NULL
activation	NULL
stimulus	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
a	NULL
representative	NULL
surface	NULL
marker	NULL
analysis	NULL
comparison	NULL
of	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
donor	NULL
that	NULL
were	NULL
activated	NULL
either	NULL
with	NULL
PHA	NULL
or	NULL
OKT3	NULL
(	NULL
shown	NULL
in	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
knowledge	NULL
that	NULL
activation-induced	NULL
genes	NULL
are	NULL
regulated	NULL
by	NULL
contingent	NULL
signals	NULL
arising	NULL
from	NULL
the	NULL
T-cell	NULL
receptor	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
23	NULL
)	NULL
,	NULL
we	NULL
then	NULL
examined	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-binding	NULL
protein	NULL
expression	NULL
in	NULL
lymphocytes	NULL
from	NULL
normal	NULL
individuals	NULL
activated	NULL
using	NULL
a	NULL
combination	NULL
of	NULL
OKT3	NULL
with	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
activator	NULL
PMA	NULL
.	NULL

We	NULL
found	NULL
that	NULL
addition	NULL
of	NULL
PMA	NULL
(	NULL
1	NULL
ng/m	NULL
!	NULL
)	NULL

to	NULL
the	NULL
OKT	NULL
3	NULL
signal	NULL
increased	NULL
the	NULL
receptor	NULL
levels	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
activation	NULL
induced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
OKT3	NULL
with	NULL
PMA	NULL
led	NULL
to	NULL
receptor	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
seen	NULL
with	NULL
the	NULL
polyclonal	NULL
activator	NULL
PHA	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
from	NULL
lymphocytes	NULL
from	NULL
one	NULL
normal	NULL
donor	NULL
is	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
seen	NULL
using	NULL
lymphocytes	NULL
from	NULL
four	NULL
different	NULL
individuals	NULL
.	NULL

The	NULL
results	NULL
of	NULL
these	NULL
experiments	NULL
collectively	NULL
indicate	NULL
that	NULL
the	NULL
:	NULL
ﬁctivation-induced	NULL
appearance	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-binding	NULL
protein-in	NULL
lymphocytes	NULL
is	NULL
not	NULL
an	NULL
all	NULL
or	NULL
nothing	NULL
phenomenon	NULL
,	NULL
neither'is	NULL
it	NULL
a	NULL
mere	NULL
consequence	NULL
of	NULL
a	NULL
general	NULL
increase	NULL
in	NULL
total	NULL
DNA	NULL
synthesis	NULL
.	NULL

Instead	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
binding	NULL
protein	NULL
appears	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
distinct	NULL
and	NULL
specific	NULL
signals	NULL
arising	NULL
from	NULL
the	NULL
T-cell	NULL
receptor	NULL
and	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
pathway	NULL
.	NULL

Effects	NULL
of	NULL
Distinct	NULL
Activation	NULL
Signals	NULL
on	NULL
the	NULL
Ability	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°HJ	NULL
]	NULL
D	NULL
;	NULL
,	NULL
Receptor	NULL
Complex	NULL
to	NULL
Bind	NULL
DNA-Cellulose-In	NULL
addition	NULL
to	NULL
comparing	NULL
signal-dependent	NULL
differences	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
receptor	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
the	NULL
different	NULL
activation	NULL
signals	NULL
may	NULL
lead	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
qualitatively	NULL
different	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
the	NULL
experiments	NULL
The	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
Receptor	NULL
in	NULL
Human	NULL
Lymphocytes	NULL
c	NULL
o	NULL
tet	NULL
2000	NULL
-	NULL
1000	NULL
3	NULL
800	NULL
-I	NULL
&	NULL
1004	NULL
g	NULL
soo	NULL
7	NULL
PHA	NULL
:	NULL
9	NULL
10004	NULL
0	NULL
400	NULL
-f	NULL
&	NULL
5	NULL
F	NULL
soo	NULL
4	NULL
200	NULL
o	NULL
I	NULL
o	NULL
I	NULL
Tor	NULL
10	NULL
20	NULL
_	NULL
tor	NULL
20007	NULL
1000	NULL
c	NULL
o	NULL
e	NULL
A	NULL
/	NULL
soo	NULL
&	NULL
-	NULL
ioo	NULL
i	NULL
soo	NULL
€	NULL
OKT3	NULL
:	NULL
92	NULL
10004	NULL
a	NULL
400	NULL
a	NULL
T	NULL
-	NULL
sood	NULL
E	NULL
200	NULL
o	NULL
0	NULL
Tor	NULL
10	NULL
20	NULL
_	NULL
ToP	NULL
FRACTION	NULL
NUMBER	NULL
(	NULL
0.2m	NULL
)	NULL
FRACTION	NULL
NUMBER	NULL
(	NULL
0.2m1	NULL
)	NULL
7591	NULL
c	NULL
o	NULL
t+	NULL
10007	NULL
<	NULL
0	NULL
*C	NULL
800	NULL
<	NULL
]	NULL
800	NULL
TOP	NULL
10	NULL
20	NULL
10007	NULL
«	NULL
+0	NULL
<	NULL
+0	NULL
800	NULL
4	NULL
d	NULL
+0	NULL
e00-400	NULL
-	NULL
]	NULL
200	NULL
0	NULL
1	NULL
TOP	NULL
10	NULL
20	NULL
FRAGTION	NULL
NUMBER	NULL
(	NULL
0.2mi	NULL
)	NULL
10	NULL
20	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
binding	NULL
(	NULL
by	NULL
sucrose	NULL
density	NULL
gradient	NULL
sedimentation	NULL
)	NULL
in	NULL
PBMC	NULL
activated	NULL
with	NULL
either	NULL
PHA	NULL
or	NULL
OKT3	NULL
.	NULL

PBMC	NULL
from	NULL
three	NULL
normal	NULL
subjects	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
the	NULL
nonadherent	NULL
subset	NULL
(	NULL
following	NULL
1	NULL
h	NULL
of	NULL
incubation	NULL
at	NULL
37	NULL
°C	NULL
)	NULL
was	NULL
incubated	NULL
for	NULL
72	NULL
h	NULL
either	NULL
with	NULL
2	NULL
ug/ml	NULL
of	NULL
the	NULL
lectin	NULL
PHA	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
with	NULL
the	NULL
monoclonal	NULL
antibody	NULL
OKT3	NULL
1:250	NULL
dilution	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
activation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
and	NULL
counted	NULL
.	NULL

Subsequently	NULL
,	NULL
equal	NULL
number	NULL
of	NULL
PHA-and	NULL
OKT3-activated	NULL
cells	NULL
(	NULL
45	NULL
x	NULL
10°	NULL
,	NULL
60	NULL
x	NULL
10°	NULL
,	NULL
75	NULL
x	NULL
10°	NULL
respectively	NULL
,	NULL
from	NULL
three	NULL
samples	NULL
)	NULL
were	NULL
incubated	NULL
intact	NULL
with	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°H	NULL
]	NULL
JD	NULL
;	NULL
(	NULL
1	NULL
x	NULL
10~°	NULL
M	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
200-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
hormone	NULL
.	NULL

Incubations	NULL
were	NULL
carried	NULL
out	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
0.2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin-saline	NULL
and	NULL
then	NULL
were	NULL
resuspended	NULL
in	NULL
0.3	NULL
ml	NULL
of	NULL
KETD-0.3	NULL
.	NULL

Cells	NULL
were	NULL
sonicated	NULL
,	NULL
and	NULL
the	NULL
sonicate	NULL
was	NULL
centrifuged	NULL
for	NULL
1	NULL
h	NULL
at	NULL
105,000	NULL
x	NULL
g	NULL
to	NULL
give	NULL
cytosol	NULL
fraction	NULL
.	NULL

Cytosols	NULL
were	NULL
layered	NULL
onto	NULL
4-24	NULL
%	NULL
sucrose	NULL
density	NULL
gradients	NULL
,	NULL
and	NULL
the	NULL
gradients	NULL
were	NULL
centrifuged	NULL
for	NULL
19	NULL
h	NULL
at	NULL
135,000	NULL
x	NULL
g.	NULL
Fractions	NULL
(	NULL
20	NULL
x	NULL
0.2	NULL
ml	NULL
)	NULL
were	NULL
collected	NULL
,	NULL
and	NULL
aliquots	NULL
were	NULL
counted	NULL
for	NULL
radioactivity	NULL
.	NULL

Solid	NULL
circles	NULL
indicate	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°HJD	NULL
;	NULL
binding	NULL
alone	NULL
;	NULL
open	NULL
circles	NULL
indicate	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°H	NULL
]	NULL
D	NULL
;	NULL
binding	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
sedimentation	NULL
markers	NULL
.	NULL

C	NULL
=	NULL
chymotrypsinogen	NULL
(	NULL
s	NULL
=	NULL
2.55	NULL
)	NULL
;	NULL
o	NULL
=	NULL
ovalbumin	NULL
(	NULL
s	NULL
=	NULL
8.75	NULL
)	NULL
.	NULL

shown	NULL
in	NULL
panels	NULL
B	NULL
and	NULL
C	NULL
,	NULL
aliquots	NULL
from	NULL
the	NULL
same	NULL
sample	NULL
of	NULL
PBMC	NULL
from	NULL
normal	NULL
donor	NULL
were	NULL
activated	NULL
either	NULL
with	NULL
PHA	NULL
or	NULL
OKT3	NULL
,	NULL
and	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°H	NULL
]	NULL
D	NULL
;	NULL
binding	NULL
was	NULL
analyzed	NULL
by	NULL
DNA	NULL
-cellulose	NULL
chromatography	NULL
.	NULL

To	NULL
eliminate	NULL
potential	NULL
artifacts	NULL
due	NULL
to	NULL
the	NULL
relatively	NULL
lower	NULL
expression	NULL
of	NULL
the	NULL
binding	NULL
protein	NULL
in	NULL
the	NULL
OKT3	NULL
system	NULL
,	NULL
we	NULL
utilized	NULL
three	NULL
times	NULL
as	NULL
many	NULL
cells	NULL
from	NULL
the	NULL
OKT3-activated	NULL
preparations	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
PHA-activated	NULL
preparations	NULL
.	NULL

For	NULL
comparison	NULL
for	NULL
these	NULL
experiments	NULL
,	NULL
DNA-cellulose	NULL
chromatography	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
[	NULL
°H	NULL
]	NULL
JD	NULL
;	NULL
binding	NULL
was	NULL
performed	NULL
using	NULL
resting	NULL
cells	NULL
and	NULL
the	NULL
profile	NULL
is	NULL
illustrated	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

The	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-binding	NULL
protein	NULL
from	NULL
PHA-activated	NULL
lymphocytes	NULL
bound	NULL
to	NULL
DNA-cellulose	NULL
,	NULL
and	NULL
during	NULL
a	NULL
0.15-0.6	NULL
M	NULL
KCl	NULL
gradient	NULL
a	NULL
peak	NULL
was	NULL
eluted	NULL
from	NULL
this	NULL
affinity	NULL
resin	NULL
at	NULL
0.28	NULL
M	NULL
KCI	NULL
.	NULL

This	NULL
behavior	NULL
is	NULL
indistinguishable	NULL
from	NULL
that	NULL
of	NULL
the	NULL
vitamin	NULL
D	NULL
receptor	NULL
of	NULL
the	NULL
classical	NULL
target	NULL
tissues	NULL
of	NULL
the	NULL
hormone	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-binding	NULL
protein	NULL
from	NULL
OKT3-activated	NULL
lymphocytes	NULL
displayed	NULL
an	NULL
altered	NULL
binding	NULL
profile	NULL
to	NULL
DNA	NULL
lose	NULL
with	NULL
no	NULL
appreciable	NULL
binding	NULL
peak	NULL
being	NULL
eluted	NULL
during	NULL
the	NULL
KCl	NULL
gradient	NULL
.	NULL

These	NULL
results	NULL
were	NULL
reproduced	NULL
using	NULL
samples	NULL
from	NULL
five	NULL
different	NULL
normal	NULL
donors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
apparent	NULL
lack	NULL
of	NULL
binding	NULL
protein	NULL
eluting	NULL
at	NULL
0.28	NULL
M	NULL
KCl	NULL
in	NULL
cytosol	NULL
from	NULL
three	NULL
times	NULL
as	NULL
many	NULL
OKT3	NULL
as	NULL
compared	NULL
to	NULL
PHA-activated	NULL
lymphocytes	NULL
indicated	NULL
that	NULL
the	NULL
difference	NULL
in	NULL
the	NULL
receptor	NULL
profile	NULL
could	NULL
not	NULL
be	NULL
accounted	NULL
by	NULL
differences	NULL
in	NULL
the	NULL
quantity	NULL
of	NULL
the	NULL
binding	NULL
protein	NULL
.	NULL

Prompted	NULL
by	NULL
the	NULL
evidence	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
PMA	NULL
to	NULL
increase	NULL
the	NULL
level	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°HJD	NULL
;	NULL
binding	NULL
in	NULL
OKT3-activated	NULL
cells	NULL
,	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
PMA	NULL
with	NULL
OKT3	NULL
might	NULL
restore	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
binding	NULL
protein	NULL
to	NULL
interact	NULL
with	NULL
DNA	NULL
was	NULL
investigated	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
panel	NULL
D	NULL
the	NULL
combination	NULL
of	NULL
the	NULL
two	NULL
stimuli	NULL
did	NULL
not	NULL
change	NULL
the	NULL
DNA-binding	NULL
profile	NULL
and	NULL
hence	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
steroid	NULL
receptor	NULL
complex	NULL
to	NULL
interact	NULL
with	NULL
DNA-cellulose	NULL
.	NULL

In	NULL
view	NULL
of	NULL
this	NULL
,	NULL
we	NULL
proceeded	NULL
to	NULL
test	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
apparent	NULL
difference	NULL
in	NULL
DNA-cellulose	NULL
binding	NULL
could	NULL
be	NULL
due	NULL
to	NULL
altered	NULL
ionic	NULL
charges	NULL
of	NULL
the	NULL
protein	NULL
in	NULL
the	NULL
OKT3	NULL
activation	NULL
system	NULL
,	NULL
using	NULL
chromatography	NULL
with	NULL
an	NULL
alternative	NULL
binding	NULL
resin	NULL
,	NULL
namely	NULL
DEAE-cellulose	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Unlike	NULL
the	NULL
case	NULL
with	NULL
DNA-cellulose	NULL
,	NULL
the	NULL
binding	NULL
protein	NULL
from	NULL
OKT3-activated	NULL
cells	NULL
bound	NULL
to	NULL
DEAE-cellulose	NULL
equally	NULL
well	NULL
to	NULL
the	NULL
binding	NULL
protein	NULL
from	NULL
PHA-activated	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
altered	NULL
ionic	NULL
changes	NULL
could	NULL
not	NULL
account	NULL
for	NULL
the	NULL
inability	NULL
of	NULL
the	NULL
receptor	NULL
from	NULL
the	NULL
OKT3	NULL
activation	NULL
system	NULL
to	NULL
interact	NULL
with	NULL
DNA-cellulose	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
Receptor-like	NULL
Binding	NULL
Protein	NULL
by	NULL
Immunoblots	NULL
and	NULL
Partial	NULL
DNA	NULL
Sequencing-In	NULL
spite	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
numerous	NULL
studies	NULL
have	NULL
independently	NULL
confirmed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
receptor-like	NULL
binding	NULL
protein	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
activated	NULL
lymphocytes	NULL
,	NULL
characterization	NULL
of	NULL
this	NULL
protein	NULL
has	NULL
been	NULL
limited	NULL
to	NULL
means	NULL
afforded	NULL
by	NULL
ligand	NULL
binding	NULL
methodology	NULL
.	NULL

To	NULL
gain	NULL
additional	NULL
information	NULL
on	NULL
this	NULL
protein	NULL
,	NULL
we	NULL
employed	NULL
immunoblotting	NULL
analysis	NULL
of	NULL
crude	NULL
cytosol	NULL
preparation	NULL
from	NULL
lymphocytes	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
raised	NULL
against	NULL
chick	NULL
intestinal	NULL
vitamin	NULL
D	NULL
receptor	NULL
(	NULL
26	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
a	NULL
cross-reacting	NULL
protein	NULL
with	NULL
an	NULL
electro-phoretic	NULL
mobility	NULL
of	NULL
approximately	NULL
50	NULL
kDa	NULL
was	NULL
seen	NULL
in	NULL
cytosol	NULL
preparations	NULL
from	NULL
both	NULL
PHA-	NULL
or	NULL
OKT3-activated	NULL
lymphocytes	NULL
.	NULL

This	NULL
protein	NULL
was	NULL
absent	NULL
in	NULL
cytosol	NULL
from	NULL
nonstimulated	NULL
lymphocytes	NULL
.	NULL

The	NULL
50-kDa	NULL
protein	NULL
from	NULL
the	NULL
activated	NULL
lymphocytes	NULL
comigrated	NULL
with	NULL
recombinant	NULL
human	NULL
intestinal	NULL
receptor	NULL
prepared	NULL
from	NULL
COS	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
carrying	NULL
the	NULL
receptor	NULL
cDNA	NULL
.	NULL

In	NULL
experiments	NULL
not	NULL
shown	NULL
here	NULL
,	NULL
the	NULL
50-kDa	NULL
protein	NULL
from	NULL
activated	NULL
lymphocytes	NULL
was	NULL
also	NULL
identified	NULL
in	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
alternative	NULL
monoclonal	NULL
antibody	NULL
(	NULL
IVGSC11	NULL
)	NULL
provided	NULL
to	NULL
us	NULL
by	NULL
Dr.	NULL
H.	NULL
DeLuca	NULL
(	NULL
University	NULL
of	NULL
Wisconsin	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
strongly	NULL
that	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
-binding	NULL
protein	NULL
from	NULL
the	NULL
activated	NULL
lymphocytes	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
protein	NULL
7592	NULL
f	NULL
3000	NULL
1.2	NULL
5	NULL
PHA	NULL
C.	NULL
5	NULL
1.0	NULL
a	NULL
E	NULL
,	NULL
10°	NULL
OKT	NULL
;	NULL
o	NULL
0.8	NULL
g	NULL
o	NULL
o	NULL
LL	NULL
0	NULL
0.5	NULL
10	NULL
15	NULL
é	NULL
o6	NULL
{	NULL
Total	NULL
[	NULL
9H11,25	NULL
(	NULL
0H	NULL
)	NULL
20	NULL
’	NULL
(	NULL
10'°u	NULL
)	NULL
3	NULL
fed	NULL
©	NULL
94	NULL
}	NULL
0.2	NULL
{	NULL
-|	NULL
1	NULL
0	NULL
10	NULL
20	NULL
Bound	NULL
[	NULL
°HJ	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
(	NULL
f	NULL
moles	NULL
/	NULL
0.16mg	NULL
Cytosol	NULL
)	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Scatchard	NULL
analysis	NULL
of	NULL
specific	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
[	NULL
°HIJD	NULL
:	NULL
binding	NULL
in	NULL
PHA-	NULL
and	NULL
OKT3-activated	NULL
PBMC	NULL
cytosol	NULL
.	NULL

PBMC	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
activated	NULL
for	NULL
72	NULL
h	NULL
either	NULL
with	NULL
the	NULL
lectin	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
or	NULL
the	NULL
monoclonal	NULL
antibody	NULL
OKT3	NULL
(	NULL
1:250	NULL
)	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
activation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
counted	NULL
.	NULL

Cytosol	NULL
from	NULL
PHA-	NULL
and	NULL
OKT3-activated	NULL
cells	NULL
(	NULL
170	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
obtained	NULL
by	NULL
sonication	NULL
and	NULL
ultracen-trifugation	NULL
(	NULL
1	NULL
h	NULL
at	NULL
105,000	NULL
x	NULL
g	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
cytosol	NULL
(	NULL
1.6	NULL
mg	NULL
of	NULL
protein/	NULL
ml	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°H	NULL
]	NULL
D	NULL
;	NULL
(	NULL
1	NULL
x	NULL
10~	NULL
``	NULL
-1.5	NULL
x	NULL
10~	NULL
M	NULL
)	NULL
alone	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
200-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

Bound	NULL
sterol	NULL
was	NULL
separated	NULL
from	NULL
free	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
ice-cold	NULL
Dextran-coated	NULL
charcoal	NULL
suspension	NULL
.	NULL

Specific	NULL
binding	NULL
from	NULL
PHA-activated	NULL
(	NULL
open	NULL
circles	NULL
)	NULL
and	NULL
OKT3-activated	NULL
(	NULL
open	NULL
triangles	NULL
)	NULL
,	NULL
derived	NULL
by	NULL
subtracting	NULL
nonspecific	NULL
from	NULL
total	NULL
binding	NULL
,	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
the	NULL
Scatchard	NULL
plots	NULL
.	NULL

expressed	NULL
constitutively	NULL
in	NULL
human	NULL
intestinal	NULL
epithelium	NULL
cells	NULL
.	NULL

Further	NULL
,	NULL
the	NULL
immunoblot	NULL
data	NULL
confirm	NULL
the	NULL
evidence	NULL
from	NULL
the	NULL
binding	NULL
studies	NULL
and	NULL
demonstrate	NULL
for	NULL
the	NULL
first	NULL
time	NULL
directly	NULL
and	NULL
independently	NULL
of	NULL
binding	NULL
that	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
protein	NULL
is	NULL
absent	NULL
from	NULL
resting	NULL
human	NULL
peripheral	NULL
blood	NULL
lym-phocytes	NULL
;	NULL
but	NULL
it	NULL
is	NULL
expressed	NULL
following	NULL
the	NULL
reception	NULL
of	NULL
external	NULL
stimulatory	NULL
signals	NULL
.	NULL

Finally	NULL
,	NULL
to	NULL
corroborate	NULL
the	NULL
evidence	NULL
from	NULL
the	NULL
immunoblots	NULL
that	NULL
lymphocytes	NULL
express	NULL
the	NULL
classical	NULL
50-kDa	NULL
human	NULL
vitamin	NULL
D	NULL
receptor	NULL
,	NULL
RNA	NULL
from	NULL
activated	NULL
cells	NULL
was	NULL
extracted	NULL
,	NULL
and	NULL
cDNA	NULL
was	NULL
synthesized	NULL
with	NULL
reverse	NULL
transcriptase	NULL
.	NULL

The	NULL
cDNA	NULL
was	NULL
then	NULL
amplified	NULL
using	NULL
primers	NULL
that	NULL
flank	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
receptor	NULL
.	NULL

After	NULL
symmetric	NULL
amplification	NULL
,	NULL
single-stranded	NULL
DNA	NULL
was	NULL
generated	NULL
using	NULL
asymmetric	NULL
amplification	NULL
and	NULL
was	NULL
sequenced	NULL
by	NULL
the	NULL
dideox-ynucleotide	NULL
chain-termination	NULL
method	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
the	NULL
amplified	NULL
sequence	NULL
from	NULL
the	NULL
activated	NULL
cells	NULL
had	NULL
an	NULL
exact	NULL
homology	NULL
with	NULL
the	NULL
195-base	NULL
pair	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
receptor	NULL
.	NULL

Identical	NULL
sequences	NULL
were	NULL
found	NULL
when	NULL
lymphocytes	NULL
were	NULL
activated	NULL
by	NULL
PHA	NULL
or	NULL
OKT3	NULL
.	NULL

This	NULL
evidence	NULL
indicates	NULL
that	NULL
the	NULL
vitamin	NULL
D	NULL
receptor	NULL
protein	NULL
in	NULL
lymphocytes	NULL
is	NULL
encoded	NULL
by	NULL
an	NULL
mRNA	NULL
species	NULL
that	NULL
is	NULL
similar	NULL
if	NULL
not	NULL
identical	NULL
to	NULL
that	NULL
expressed	NULL
in	NULL
the	NULL
classical	NULL
target	NULL
issues	NULL
of	NULL
the	NULL
hormone	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
addressed	NULL
in	NULL
this	NULL
study	NULL
questions	NULL
concerning	NULL
how	NULL
the	NULL
vitamin	NULL
D	NULL
receptor	NULL
gene	NULL
is	NULL
regulated	NULL
in	NULL
lymphocytes	NULL
and	NULL
whether	NULL
there	NULL
are	NULL
tissue-specific	NULL
differences	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
the	NULL
post-transcriptional	NULL
or	NULL
post-translational	NULL
The	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
)	NULL
3	NULL
Receptor	NULL
in	NULL
Human	NULL
Lymphocytes	NULL
50	NULL
(	NULL
100	NULL
©	NULL
26:15	NULL
3	NULL
&	NULL
A40p-	NULL
gnu	NULL
£	NULL
m	NULL
(	NULL
=	NULL
E	NULL
8	NULL
£~*	NULL
[	NULL
++	NULL
]	NULL
ano	NULL
‘	NULL
3°L	NULL
°	NULL
46hra	NULL
Tahre	NULL
S6hra	NULL
o	NULL
X	NULL
<	NULL
4	NULL
O	NULL
a	NULL
Ner	NULL
2	NULL
20F-i	NULL
o	NULL
_	NULL
E	NULL
ga	NULL
&	NULL
-E	NULL
“	NULL
u	NULL
10k	NULL
o	NULL
La	NULL
M	NULL
1	NULL
.	NULL

_1	NULL
0	NULL
24	NULL
48	NULL
72	NULL
96	NULL
Hours	NULL
in	NULL
Culture	NULL
FiG	NULL
.	NULL

3	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptors	NULL
in	NULL
PHA-	NULL
and	NULL
OKT3-stimulated	NULL
PBMC	NULL
.	NULL

PBMC	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
activated	NULL
with	NULL
PHA	NULL
(	NULL
O	NULL
--	NULL
O	NULL
)	NULL
and	NULL
OKT3	NULL
antibody	NULL
(	NULL
A	NULL
--	NULL
A	NULL
)	NULL
for	NULL
up	NULL
to	NULL
4	NULL
days	NULL
.	NULL

At	NULL
various	NULL
time	NULL
points	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
,	NULL
counted	NULL
,	NULL
and	NULL
aliquots	NULL
of	NULL
2	NULL
X	NULL
10°/0.1	NULL
ml	NULL
were	NULL
incubated	NULL
intact	NULL
in	NULL
triplicate	NULL
with	NULL
1	NULL
x	NULL
107°	NULL
m	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°H	NULL
]	NULL
D	NULL
;	NULL
alone	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
1	NULL
h	NULL
at	NULL
20°C	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
isotonic	NULL
buffer	NULL
supplemented	NULL
with	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
2	NULL
mg/ml	NULL
)	NULL
and	NULL
solubilized	NULL
with	NULL
Protosol	NULL
.	NULL

The	NULL
internalized	NULL
radioactivity	NULL
was	NULL
counted	NULL
,	NULL
and	NULL
specific	NULL
binding	NULL
(	NULL
total	NULL
minus	NULL
nonspecific	NULL
)	NULL
was	NULL
plotted	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
DNA	NULL
synthesis	NULL
(	NULL
PHA	NULL
activated	NULL
,	NULL
shaded	NULL
bar	NULL
;	NULL
OKT3	NULL
activated	NULL
,	NULL
open	NULL
bar	NULL
)	NULL
at	NULL
each	NULL
indicated	NULL
time	NULL
point	NULL
was	NULL
also	NULL
determined	NULL
by	NULL
pulsing	NULL
cell	NULL
aliquots	NULL
with	NULL
for	NULL
the	NULL
last	NULL
19	NULL
h	NULL
of	NULL
activation	NULL
(	NULL
inset	NULL
)	NULL
.	NULL

TABLE	NULL
I	NULL
Surface	NULL
marker	NULL
analysis	NULL
of	NULL
PHA	NULL
and	NULL
OKT3-activated	NULL
PBMC	NULL
PBMC	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
incubated	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
NS	NULL
=	NULL
not	NULL
stimulated	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
or	NULL
OKT3	NULL
(	NULL
1:250	NULL
)	NULL
for	NULL
72	NULL
h.	NULL
At	NULL
the	NULL
end	NULL
of	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
counted	NULL
.	NULL

Cell	NULL
aliquots	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
then	NULL
washed	NULL
in	NULL
PBS	NULL
with	NULL
1	NULL
%	NULL
sodium	NULL
azide	NULL
and	NULL
1	NULL
%	NULL
BSA	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
Anti-leu-3a	NULL
{	NULL
CD4	NULL
]	NULL
and	NULL
anti-leu-2a	NULL
[	NULL
CD8	NULL
]	NULL
)	NULL
directly	NULL
conjugated	NULL
with	NULL
fluorescein	NULL
and	NULL
phycoerythrin	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Stained	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
,	NULL
fixed	NULL
in	NULL
1.0	NULL
ml	NULL
of	NULL
PBS	NULL
with	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
Coulter	NULL
Epics	NULL
Profile	NULL
II	NULL
flow	NULL
cytometer	NULL
.	NULL

Values	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
positive	NULL
cells	NULL
.	NULL

Activation	NULL
-	NULL
Total/T4	NULL
-	NULL
Total/T8	NULL
T4/T8	NULL
-	NULL
T4/IL-2R	NULL
|	NULL
T8/IL-2R	NULL
PHA	NULL
41	NULL
66	NULL
0.6	NULL
39	NULL
55	NULL
OKT3	NULL
36	NULL
54	NULL
0.7	NULL
34	NULL
42	NULL
NS	NULL
34	NULL
29	NULL
1.2	NULL
3	NULL
0	NULL
processing	NULL
of	NULL
the	NULL
gene	NULL
product	NULL
,	NULL
or	NULL
more	NULL
than	NULL
one	NULL
type	NULL
of	NULL
mRNA	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
in	NULL
lymphocytes	NULL
activated	NULL
with	NULL
the	NULL
OKT3	NULL
monoclonal	NULL
antibody	NULL
which	NULL
mediates	NULL
only	NULL
a	NULL
subset	NULL
of	NULL
intracellular	NULL
events	NULL
,	NULL
fewer	NULL
binding	NULL
sites	NULL
are	NULL
expressed	NULL
as	NULL
compared	NULL
to	NULL
lymphocytes	NULL
activated	NULL
with	NULL
the	NULL
mitogenic	NULL
lectin	NULL
PHA	NULL
,	NULL
a	NULL
polyclonal	NULL
activator	NULL
capable	NULL
of	NULL
eliciting	NULL
a	NULL
more	NULL
complete	NULL
activation	NULL
response	NULL
.	NULL

Nevertheless	NULL
,	NULL
when	NULL
the	NULL
signal	NULL
of	NULL
OKT3	NULL
was	NULL
combined	NULL
with	NULL
that	NULL
of	NULL
a	NULL
protein	NULL
kinase	NULL
C	NULL
activator	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
binding	NULL
sites	NULL
increased	NULL
to	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
produced	NULL
by	NULL
the	NULL
polyclonal	NULL
activator	NULL
PHA	NULL
.	NULL

The	NULL
increase	NULL
of	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
induced	NULL
by	NULL
the	NULL
OKT3	NULL
signal	NULL
by	NULL
PMA	NULL
is	NULL
in	NULL
line	NULL
with	NULL
evidence	NULL
from	NULL
other	NULL
activation-induced	NULL
genes	NULL
in	NULL
lymphocytes	NULL
The	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
Receptor	NULL
in	NULL
Human	NULL
Lymphocytes	NULL
7593	NULL
A.	NULL
PHA	NULL
~	NULL
activated	NULL
B.	NULL
OKT	NULL
,	NULL
-	NULL
activated	NULL
C.	NULL
OKT3	NULL
+	NULL
PMA	NULL
-	NULL
activated	NULL
c	NULL
o	NULL
1000	NULL
00	NULL
c	NULL
o	NULL
1000	NULL
c	NULL
o	NULL
1000	NULL
t+	NULL
~	NULL
o	NULL
_s	NULL
=	NULL
A	NULL
26	NULL
-	NULL
soo	NULL
500	NULL
soo	NULL
F	NULL
led	NULL
=	NULL
mun-55/0	NULL
%	NULL
%	NULL
0	NULL
$	NULL
8	NULL
o	NULL
Tor	NULL
10	NULL
20	NULL
Tor	NULL
10	NULL
20	NULL
Tor	NULL
10	NULL
20	NULL
FRACTION	NULL
NUMBER	NULL
(	NULL
0.2m1	NULL
)	NULL
FRACTION	NULL
NUMBER	NULL
(	NULL
0.2m1	NULL
)	NULL
FRACTION	NULL
NUMBER	NULL
(	NULL
0.2m1	NULL
)	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Sucrose	NULL
density	NULL
gradient	NULL
sedimentation	NULL
analysis	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°HJD	NULL
;	NULL
binding	NULL
in	NULL
PHA-	NULL
,	NULL
OKT3-	NULL
,	NULL
and	NULL
OKT3	NULL
+	NULL
PMA-activated	NULL
PBMC	NULL
.	NULL

PBMC	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
activated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
the	NULL
lectin	NULL
PHA	NULL
(	NULL
2	NULL
ug/m	NULL
!	NULL
)	NULL

,	NULL
the	NULL
monoclonal	NULL
antibody	NULL
OKT3	NULL
(	NULL
1:250	NULL
)	NULL
,	NULL
or	NULL
combination	NULL
of	NULL
OKT3	NULL
+	NULL
PMA	NULL
(	NULL
1	NULL
ng/m	NULL
!	NULL
)	NULL

.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
activation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
counted	NULL
.	NULL

Aliquots	NULL
(	NULL
75	NULL
x	NULL
10°	NULL
)	NULL
of	NULL
PHA-	NULL
,	NULL
OKT3-	NULL
,	NULL
and	NULL
OKT3	NULL
+	NULL
PMA	NULL
-activated	NULL
cells	NULL
were	NULL
incubated	NULL
intact	NULL
with	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°H	NULL
]	NULL
}	NULL
D	NULL
;	NULL
(	NULL
1	NULL
x	NULL
107°	NULL
m	NULL
)	NULL
alone	NULL
(	NULL
solid	NULL
circles	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
200-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
open	NULL
circles	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
cytosols	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
on	NULL
sucrose	NULL
density	NULL
gradient	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

C	NULL
and	NULL
O	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
sedimentation	NULL
markers	NULL
.	NULL

0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
FRACTION	NULL
NUMBER	NULL
(	NULL
3m	NULL
!	NULL
)	NULL

2°°W	NULL
A	NULL
.	NULL

Resting	NULL
Lymphocytes	NULL
2007	NULL
B.	NULL
PHA	NULL
-	NULL
activated	NULL
m	NULL
o	NULL
28	NULL
-	NULL
150-7	NULL
150	NULL
T	NULL
5	NULL
,	NULL
2	NULL
pes	NULL
_	NULL
@	NULL
§	NULL
1007	NULL
-*	NULL
``	NULL
0.4	NULL
1004	NULL
H	NULL
-	NULL
a	NULL
0	NULL
~	NULL
0.3	NULL
x	NULL
€	NULL
1	NULL
&	NULL
so-	NULL
0.2	NULL
-	NULL
§s0	NULL
~	NULL
]	NULL
t	NULL
0.1	NULL
0	NULL
-	NULL
o	NULL
zo	NULL
-	NULL
30	NULL
_	NULL
40	NULL
0	NULL
-	NULL
10	NULL
zo	NULL
-	NULL
30	NULL
_	NULL
40	NULL
2°01	NULL
C.	NULL
OKT3	NULL
-	NULL
activated	NULL
&	NULL
o	NULL
A	NULL
I	NULL
a	NULL
2e	NULL
3	NULL
a§	NULL
3	NULL
~	NULL
t	NULL
T	NULL
1	NULL
o	NULL
.	NULL

1	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
FRACTION	NULL
NUMBER	NULL
(	NULL
3m1	NULL
)	NULL
FiG	NULL
.	NULL

5	NULL
.	NULL

DNA-cellulose	NULL
chromatography	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
isolated	NULL
from	NULL
resting	NULL
,	NULL
PHA-	NULL
,	NULL
OKT3-	NULL
,	NULL
or	NULL
OKT3	NULL
+	NULL
PMA	NULL
-activated	NULL
lymphocytes	NULL
.	NULL

PBMC	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
incubated	NULL
for	NULL
72	NULL
h	NULL
either	NULL
without	NULL
any	NULL
additions	NULL
(	NULL
panel	NULL
A	NULL
)	NULL
or	NULL
with	NULL
2	NULL
ug/ml	NULL
PHA	NULL
(	NULL
panel	NULL
B	NULL
)	NULL
,	NULL
OKT3	NULL
(	NULL
1:250	NULL
dilution	NULL
)	NULL
(	NULL
panel	NULL
C	NULL
)	NULL
,	NULL
or	NULL
OKT3	NULL
+	NULL
PMA	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
(	NULL
panel	NULL
D	NULL
)	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
72-h	NULL
incubation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
counted	NULL
.	NULL

Cell	NULL
aliquots	NULL
(	NULL
116	NULL
x	NULL
10°	NULL
from	NULL
resting	NULL
cells	NULL
,	NULL
43	NULL
x	NULL
10°	NULL
from	NULL
PHA-activated	NULL
,	NULL
132	NULL
x	NULL
10°	NULL
from	NULL
OKT3-activated	NULL
,	NULL
204	NULL
x	NULL
10°	NULL
from	NULL
OKT3	NULL
+	NULL
PMA-activated	NULL
)	NULL
were	NULL
incubated	NULL
intact	NULL
with	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
(	NULL
°HIJD	NULL
;	NULL
(	NULL
2	NULL
x	NULL
10~°	NULL
M	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
20	NULL
°C	NULL
,	NULL
and	NULL
then	NULL
cytosols	NULL
were	NULL
obtained	NULL
after	NULL
sonication	NULL
and	NULL
ultracentrifugation	NULL
.	NULL

Proteins	NULL
were	NULL
then	NULL
precipitated	NULL
with	NULL
ammonium	NULL
sulfate	NULL
(	NULL
40	NULL
%	NULL
of	NULL
saturation	NULL
)	NULL
for	NULL
30	NULL
min	NULL
,	NULL
resolubilized	NULL
,	NULL
and	NULL
then	NULL
applied	NULL
to	NULL
DNA-cellulose	NULL
column	NULL
.	NULL

The	NULL
columns	NULL
were	NULL
washed	NULL
with	NULL
30	NULL
ml	NULL
of	NULL
buffer	NULL
containing	NULL
no	NULL
KCI	NULL
,	NULL
30	NULL
ml	NULL
of	NULL
buffer	NULL
containing	NULL
0.15	NULL
M	NULL
KCI	NULL
followed	NULL
by	NULL
a	NULL
90-ml	NULL
linear	NULL
gradient	NULL
of	NULL
KCI	NULL
(	NULL
0.15-0.6	NULL
M	NULL
)	NULL
.	NULL

Fractions	NULL
(	NULL
3	NULL
ml	NULL
)	NULL
were	NULL
collected	NULL
and	NULL
aliquots	NULL
were	NULL
counted	NULL
for	NULL
tritium	NULL
(	NULL
@	NULL
--	NULL
®	NULL
@	NULL
)	NULL
.	NULL

Salt	NULL
concentrations	NULL
(	NULL
-	NULL
-	NULL
-	NULL
)	NULL
were	NULL
monitored	NULL
by	NULL
conductivity	NULL
measurements	NULL
.	NULL

Arrow	NULL
indicates	NULL
salt	NULL
concentrations	NULL
at	NULL
which	NULL
the	NULL
major	NULL
peak	NULL
was	NULL
eluted	NULL
.	NULL

and	NULL
supports	NULL
the	NULL
contention	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
receptor	NULL
in	NULL
lymphocytes	NULL
in	NULL
vivo	NULL
might	NULL
indeed	NULL
be	NULL
under	NULL
the	NULL
control	NULL
of	NULL
contingent	NULL
signals	NULL
including	NULL
those	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
pathway	NULL
.	NULL

Interestingly	NULL
,	NULL
an	NULL
upregulatory	NULL
effect	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
system	NULL
on	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
has	NULL
been	NULL
described	NULL
recently	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
present	NULL
study	NULL
also	NULL
illustrate	NULL
that	NULL
the	NULL
rate	NULL
of	NULL
DNA	NULL
synthesis	NULL
in	NULL
lymphocytes	NULL
is	NULL
clearly	NULL
dissociated	NULL
from	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
protein	NULL
.	NULL

This	NULL
evidence	NULL
,	NULL
contrasts	NULL
with	NULL
earlier	NULL
studies	NULL
by	NULL
Feldman	NULL
and	NULL
colleagues	NULL
(	NULL
33	NULL
)	NULL
,	NULL
who	NULL
found	NULL
that	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
expression	NULL
is	NULL
a	NULL
function	NULL
of	NULL
DNA	NULL
synthesis	NULL
in	NULL
established	NULL
osteosarcoma	NULL
lines	NULL
.	NULL

However	NULL
,	NULL
our	NULL
data	NULL
are	NULL
in	NULL
full	NULL
agreement	NULL
with	NULL
more	NULL
recent	NULL
results	NULL
from	NULL
the	NULL
same	NULL
group	NULL
indicating	NULL
that	NULL
receptor	NULL
regulation	NULL
by	NULL
growth	NULL
factors	NULL
is	NULL
independent	NULL
of	NULL
the	NULL
rate	NULL
of	NULL
DNA	NULL
synthesis	NULL
(	NULL
34	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
quantitative	NULL
differences	NULL
in	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
,	NULL
the	NULL
data	NULL
of	NULL
this	NULL
paper	NULL
document	NULL
signal-dependent	NULL
qualitative	NULL
differences	NULL
of	NULL
the	NULL
protein	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
altered	NULL
behavior	NULL
of	NULL
the	NULL
receptor-1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
complex	NULL
from	NULL
OKT3-activated	NULL
cells	NULL
during	NULL
DNA-cellulose	NULL
chromatography	NULL
.	NULL

This	NULL
qualitative	NULL
difference	NULL
was	NULL
a	NULL
consistent	NULL
finding	NULL
in	NULL
lymphocyte	NULL
preparations	NULL
from	NULL
as	NULL
many	NULL
as	NULL
six	NULL
different	NULL
normal	NULL
subjects	NULL
we	NULL
have	NULL
studied	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
possibility	NULL
of	NULL
prote-olytic	NULL
damage	NULL
,	NULL
in	NULL
three	NULL
out	NULL
of	NULL
the	NULL
six	NULL
replicate	NULL
experiments	NULL
we	NULL
added	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
to	NULL
the	NULL
cytosol	NULL
buffer	NULL
which	NULL
already	NULL
contained	NULL
dithiothreitol	NULL
.	NULL

This	NULL
,	NULL
however	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
behavior	NULL
of	NULL
the	NULL
receptor	NULL
from	NULL
either	NULL
the	NULL
PHA-	NULL
or	NULL
the	NULL
OKT3-activated	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
all	NULL
six	NULL
replicate	NULL
experiments	NULL
the	NULL
second	NULL
peak	NULL
of	NULL
the	NULL
DNA-cellulose	NULL
chromatography	NULL
,	NULL
which	NULL
was	NULL
perhaps	NULL
modified	NULL
receptor	NULL
that	NULL
7594	NULL
A.	NULL
PHA	NULL
-	NULL
ACTIVATED	NULL
PBMC	NULL
2,500	NULL
2,000	NULL
cpm	NULL
Pr	NULL
&	NULL
n	NULL
o	NULL
3	NULL
[	NULL
3	NULL
]	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
P	NULL
;	NULL
8	NULL
o	NULL
B	NULL
500	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
FRACTION	NULL
NUMBER	NULL
(	NULL
3m	NULL
)	NULL
The	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
Receptor	NULL
in	NULL
Human	NULL
Lymphocytes	NULL
B.	NULL
OKT3	NULL
-	NULL
ACTIVATED	NULL
PBMC	NULL
500	NULL
--	NULL
-	NULL
KCI	NULL
(	NULL
M	NULL
)	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
60	NULL
FRACTION	NULL
NUMBER	NULL
(	NULL
3mi	NULL
)	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

DEAE-cellulose	NULL
chromatography	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
s	NULL
receptor	NULL
in	NULL
activated	NULL
PBMC	NULL
.	NULL

PBMC	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
activated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
either	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
or	NULL
OKT3	NULL
(	NULL
1:250	NULL
)	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
activation	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
counted	NULL
.	NULL

Aliquots	NULL
(	NULL
292	NULL
x	NULL
10°	NULL
of	NULL
PHA-activated	NULL
,	NULL
272	NULL
x	NULL
10°	NULL
of	NULL
OKT3-activated	NULL
)	NULL
were	NULL
then	NULL
incubated	NULL
intact	NULL
with	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
[	NULL
°HJD	NULL
;	NULL
(	NULL
2	NULL
x	NULL
107°	NULL
M	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
the	NULL
cytosol	NULL
fractions	NULL
were	NULL
obtained	NULL
by	NULL
ultracentrifugation	NULL
.	NULL

Ammonium	NULL
sulfate	NULL
precipitates	NULL
of	NULL
cytosols	NULL
from	NULL
PHA-	NULL
or	NULL
OKT3-activated	NULL
cells	NULL
were	NULL
applied	NULL
to	NULL
a	NULL
15-ml	NULL
column	NULL
of	NULL
DEAE-cellulose	NULL
.	NULL

The	NULL
columns	NULL
were	NULL
washed	NULL
with	NULL
60	NULL
ml	NULL
of	NULL
buffer	NULL
containing	NULL
no	NULL
KCl	NULL
,	NULL
and	NULL
then	NULL
eluted	NULL
with	NULL
a	NULL
90-ml	NULL
linear	NULL
gradient	NULL
of	NULL
KCI	NULL
(	NULL
0-0.6	NULL
M	NULL
)	NULL
.	NULL

Fractions	NULL
(	NULL
3	NULL
ml	NULL
)	NULL
were	NULL
collected	NULL
and	NULL
analyzed	NULL
for	NULL
radioactivity	NULL
(	NULL
@	NULL
--	NULL
®	NULL
)	NULL
and	NULL
salt	NULL
concentration	NULL
(	NULL
-	NULL
--	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

7	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
in	NULL
activated	NULL
human	NULL
lymphocytes	NULL
.	NULL

PBMC	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
incubated	NULL
for	NULL
72	NULL
h	NULL
without	NULL
stimuli	NULL
or	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
or	NULL
OKT3	NULL
(	NULL
1:250	NULL
)	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
incubation	NULL
,	NULL
cytosols	NULL
were	NULL
prepared	NULL
by	NULL
sonication	NULL
and	NULL
ultracentrifugation	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
cytosol	NULL
(	NULL
containing	NULL
100	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
and	NULL
enriched	NULL
preparation	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
vitamin	NULL
D	NULL
receptor	NULL
from	NULL
transfected	NULL
COS	NULL
cells	NULL
(	NULL
containing	NULL
approximately	NULL
15	NULL
fmole	NULL
of	NULL
receptor	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
then	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
incubated	NULL
with	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
2	NULL
ug/ml	NULL
9A7y	NULL
monoclonal	NULL
antibody	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Following	NULL
washing	NULL
with	NULL
TBS	NULL
with	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
%	NULL
BSA-PBS	NULL
containing	NULL
the	NULL
secondary	NULL
antibody	NULL
(	NULL
rabbit	NULL
anti-rat	NULL
IgG	NULL
,	NULL
1:2,000	NULL
dilution	NULL
of	NULL
1	NULL
mg/ml	NULL
)	NULL
overnight	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

The	NULL
nitrocellulose	NULL
was	NULL
rewashed	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
radioiodinated	NULL
protein	NULL
A	NULL
for	NULL
3	NULL
h	NULL
at	NULL
22	NULL
°C	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
dried	NULL
and	NULL
then	NULL
autoradiographed	NULL
at	NULL
-70	NULL
°C	NULL
on	NULL
Kodak	NULL
X-Omat	NULL
AR	NULL
film	NULL
for	NULL
120	NULL
h.	NULL
Lanes	NULL
1	NULL
and	NULL
5	NULL
,	NULL
15	NULL
fmol	NULL
of	NULL
enriched	NULL
human	NULL
intestinal	NULL
vitamin	NULL
D	NULL
receptor	NULL
preparations	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
nonstimulated	NULL
lymphocyte	NULL
cytosol	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
PHA-activated	NULL
lymphocyte	NULL
cytosol	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
OKT3-activated	NULL
lymphocyte	NULL
cytosol	NULL
.	NULL

had	NULL
lost	NULL
partial	NULL
DNA	NULL
binding	NULL
,	NULL
did	NULL
not	NULL
differ	NULL
between	NULL
OKT3-and	NULL
PHA	NULL
-activated	NULL
cells	NULL
.	NULL

This	NULL
rules	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
difference	NULL
was	NULL
due	NULL
to	NULL
coincidental	NULL
variability	NULL
of	NULL
the	NULL
receptor	NULL
protein	NULL
in	NULL
different	NULL
individuals	NULL
or	NULL
random	NULL
experimental	NULL
artifacts	NULL
.	NULL

It	NULL
is	NULL
equally	NULL
unlikely	NULL
that	NULL
the	NULL
``	NULL
altered	NULL
``	NULL
DNA	NULL
binding	NULL
ability	NULL
of	NULL
the	NULL
receptor-ligand	NULL
complex	NULL
from	NULL
cells	NULL
activated	NULL
via	NULL
the	NULL
partial	NULL
signal	NULL
of	NULL
OKT3	NULL
was	NULL
due	NULL
to	NULL
altered	NULL
ionic	NULL
charges	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
demonstration	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
complex	NULL
to	NULL
bind	NULL
DEAE-cellulose	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
evidence	NULL
for	NULL
identical	NULL
sequence	NULL
of	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
OKT3-	NULL
and	NULL
PHA	NULL
-activated	NULL
cells	NULL
argues	NULL
against	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
difference	NULL
could	NULL
be	NULL
due	NULL
to	NULL
alternative	NULL
mRNAs	NULL
expressed	NULL
in	NULL
response	NULL
to	NULL
different	NULL
signals	NULL
.	NULL

We	NULL
currently	NULL
can	NULL
not	NULL
provide	NULL
a	NULL
mechanistic	NULL
explanation	NULL
of	NULL
this	NULL
observation	NULL
.	NULL

Nevertheless	NULL
,	NULL
recent	NULL
evidence	NULL
that	NULL
phosphorylation	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
receptor	NULL
might	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
DNA	NULL
(	NULL
35	NULL
)	NULL
,	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
qualitative	NULL
differences	NULL
seen	NULL
in	NULL
our	NULL
studies	NULL
might	NULL
reflect	NULL
differences	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

2	NULL
/	NULL
TGTGGGGTGTGTGGAGACCGAGCCACTGGCTTTCACTTCAATGCTAT	NULL
INTESTINAL	NULL
PBMC	NULL
BGTGGGGTGTGTGGAGACCEAGCCACTGGCWCACTTCMTGCTAT	NULL
GACCTGTGAAGGCTGCAAAGGCTTCTTCAGGCGAAGCATGAA	NULL
GACCTGTGAAGGCTGCAAAGGCTTCTTCAGGCGAAGCATGAA	NULL
GCGGAAGGCACTATTCACCTGCCCCTTCAACGGGGACTGCCGC	NULL
GCGGAAGGCACTATTCACCTGCCCCTTCAACGGGGACTGCCGC	NULL
ATCACCAAGGACAACCGACGCCACTGCCAGGCCTGCCGGCT	NULL
ATCACCAAGGACAACCGACGCCACTGCCAGGCCTGCCGGCT	NULL
CAAACGCTGTGTGGACATCGGCATGATGAA	NULL
}	NULL
.	NULL

CaaACGCTGTGTGGACATCGGCATGATGAA	NULL
'	NULL
Fic	NULL
.	NULL

8	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
known	NULL
sequence	NULL
of	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
human	NULL
intestinal	NULL
receptor	NULL
with	NULL
receptor	NULL
from	NULL
activated	NULL
PBMC	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
gradient	NULL
centrifugation	NULL
and	NULL
activated	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
for	NULL
24	NULL
h.	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
activated	NULL
cells	NULL
using	NULL
the	NULL
guanidinium-isothiocyanate	NULL
method	NULL
.	NULL

Specific	NULL
oligonucleotide	NULL
primers	NULL
A	NULL
and	NULL
B	NULL
(	NULL
flanking	NULL
the	NULL
196	NULL
bp	NULL
long	NULL
region	NULL
encoding	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
the	NULL
human	NULL
intestinal	NULL
vitamin	NULL
D	NULL
receptor	NULL
)	NULL
for	NULL
reverse	NULL
transcription	NULL
polymerase	NULL
chain	NULL
reaction	NULL
and	NULL
primers	NULL
for	NULL
sequencing	NULL
were	NULL
designed	NULL
from	NULL
the	NULL
published	NULL
cDNA	NULL
sequence	NULL
of	NULL
human	NULL
intestinal	NULL
vitamin	NULL
D	NULL
receptor	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
2-5	NULL
ug	NULL
)	NULL
was	NULL
reverse	NULL
transcribed	NULL
with	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
and	NULL
primer	NULL
B.	NULL
cDNA	NULL
was	NULL
amplified	NULL
with	NULL
Tag	NULL
DNA	NULL
polymerase	NULL
and	NULL
gene-specific	NULL
primers	NULL
A	NULL
and	NULL
B	NULL
during	NULL
35	NULL
cycles	NULL
on	NULL
a	NULL
Perkin-Elmer	NULL
Cetus	NULL
PCR	NULL
DNA	NULL
Thermocycler	NULL
.	NULL

Single-stranded	NULL
DNA	NULL
was	NULL
generated	NULL
by	NULL
performing	NULL
asymmetric	NULL
PCR	NULL
(	NULL
ratio	NULL
of	NULL
two	NULL
primers	NULL
in	NULL
50:1	NULL
)	NULL
and	NULL
sequenced	NULL
by	NULL
the	NULL
chain	NULL
termination	NULL
method	NULL
using	NULL
dd	NULL
NTPs	NULL
as	NULL
inhibitors	NULL
and	NULL
Sequenase	NULL
.	NULL

Identical	NULL
sequences	NULL
were	NULL
obtained	NULL
in	NULL
PBMC	NULL
activated	NULL
with	NULL
OKT3	NULL
.	NULL

We	NULL
have	NULL
found	NULL
in	NULL
previous	NULL
work	NULL
that	NULL
unlike	NULL
PHA-activated	NULL
cells	NULL
,	NULL
lymphocytes	NULL
activated	NULL
with	NULL
OKT3	NULL
fail	NULL
to	NULL
respond	NULL
to	NULL
the	NULL
antiproliferative	NULL
effect	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Although	NULL
other	NULL
possibilities	NULL
might	NULL
account	NULL
for	NULL
the	NULL
inability	NULL
of	NULL
OKT3-activated	NULL
lymphocytes	NULL
to	NULL
respond	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
this	NULL
phenomenon	NULL
might	NULL
be	NULL
related	NULL
to	NULL
the	NULL
defective	NULL
DNA-cellulose	NULL
binding	NULL
of	NULL
the	NULL
receptor	NULL
observed	NULL
here	NULL
,	NULL
in	NULL
the	NULL
OKT3-activated	NULL
cells	NULL
.	NULL

Although	NULL
PMA	NULL
increased	NULL
the	NULL
concentration	NULL
of	NULL
binding	NULL
sites	NULL
in	NULL
OKT3-activated	NULL
cells	NULL
,	NULL
we	NULL
found	NULL
that	NULL
combination	NULL
of	NULL
PMA	NULL
with	NULL
OKT3	NULL
failed	NULL
to	NULL
restore	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
receptor	NULL
to	NULL
bind	NULL
DNA	NULL
In	NULL
our	NULL
previous	NULL
work	NULL
(	NULL
14	NULL
)	NULL
,	NULL
we	NULL
used	NULL
extensively	NULL
purified	NULL
lymphocytes	NULL
,	NULL
i.e	NULL
.	NULL

fully	NULL
devoid	NULL
of	NULL
monocytes	NULL
,	NULL
and	NULL
activated	NULL
them	NULL
using	NULL
a	NULL
combination	NULL
of	NULL
PHA	NULL
+	NULL
PMA	NULL
.	NULL

This	NULL
combination	NULL
of	NULL
stimuli	NULL
was	NULL
dictated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
pure	NULL
T-cells	NULL
can	NULL
not	NULL
be	NULL
activated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
monocytes	NULL
unless	NULL
the	NULL
monocyte	NULL
requirement	NULL
is	NULL
substituted	NULL
by	NULL
phorbol	NULL
esters	NULL
or	NULL
other	NULL
agents	NULL
that	NULL
activate	NULL
protein	NULL
kinase	NULL
C.	NULL
We	NULL
found	NULL
that	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
in	NULL
the	NULL
mono	NULL
The	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
Receptor	NULL
in	NULL
Human	NULL
Lymphocytes	NULL
cyte-depleted	NULL
lymphocytes	NULL
was	NULL
15-20-fold	NULL
less	NULL
as	NULL
compared	NULL
to	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
monocyte-replete	NULL
preparations	NULL
of	NULL
the	NULL
lymphocytes	NULL
activated	NULL
with	NULL
PHA	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
receptor	NULL
expression	NULL
in	NULL
lymphocytes	NULL
,	NULL
the	NULL
monocyte	NULL
signal	NULL
is	NULL
more	NULL
complex	NULL
than	NULL
protein	NULL
kinase	NULL
C	NULL
activation	NULL
by	NULL
the	NULL
phorbol	NULL
ester	NULL
.	NULL

Considering	NULL
this	NULL
,	NULL
the	NULL
finding	NULL
for	NULL
the	NULL
inability	NULL
of	NULL
PMA	NULL
to	NULL
restore	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
OKT3-activated	NULL
cells	NULL
,	NULL
could	NULL
be	NULL
due	NULL
to	NULL
bypassing	NULL
monocyte-derived	NULL
signals	NULL
which	NULL
may	NULL
post-transla-tionally	NULL
influence	NULL
the	NULL
protein	NULL
and	NULL
thus	NULL
its	NULL
DNA	NULL
binding	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
investigating	NULL
the	NULL
signal	NULL
requirements	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
binding	NULL
in	NULL
activated	NULL
lymphocytes	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
induced	NULL
binding	NULL
protein	NULL
using	NULL
Western	NULL
blot	NULL
analysis	NULL
and	NULL
DNA	NULL
sequencing	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
establish	NULL
that	NULL
the	NULL
protein	NULL
and	NULL
the	NULL
mRNA	NULL
encoding	NULL
it	NULL
are	NULL
identical	NULL
to	NULL
those	NULL
found	NULL
earlier	NULL
in	NULL
the	NULL
classical	NULL
target	NULL
tissues	NULL
of	NULL
the	NULL
hormone	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
results	NULL
of	NULL
the	NULL
immunoblots	NULL
strongly	NULL
support	NULL
a	NULL
de	NULL
novo	NULL
expression	NULL
of	NULL
the	NULL
receptor	NULL
protein	NULL
following	NULL
lymphocyte	NULL
activation	NULL
.	NULL

To	NULL
our	NULL
knowledge	NULL
,	NULL
such	NULL
de	NULL
novo	NULL
expression	NULL
of	NULL
this	NULL
receptor	NULL
is	NULL
unique	NULL
to	NULL
lymphocytes	NULL
since	NULL
in	NULL
all	NULL
other	NULL
known	NULL
target	NULL
cells	NULL
of	NULL
the	NULL
hormone	NULL
,	NULL
the	NULL
receptor	NULL
is	NULL
constitutively	NULL
expressed	NULL
.	NULL

Although	NULL
not	NULL
proven	NULL
,	NULL
the	NULL
phenomenon	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
protein	NULL
upon	NULL
activation	NULL
is	NULL
more	NULL
likely	NULL
due	NULL
to	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
receptor	NULL
gene	NULL
.	NULL

This	NULL
would	NULL
suggest	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
that	NULL
the	NULL
gene	NULL
in	NULL
resting	NULL
lymphocytes	NULL
is	NULL
repressed	NULL
and	NULL
that	NULL
activation	NULL
signals	NULL
act	NULL
to	NULL
derepress	NULL
it	NULL
.	NULL

Direct	NULL
investigation	NULL
of	NULL
this	NULL
will	NULL
of	NULL
course	NULL
require	NULL
isolation	NULL
of	NULL
the	NULL
gene	NULL
promoter	NULL
and	NULL
identification	NULL
of	NULL
its	NULL
regulatory	NULL
elements	NULL
.	NULL

We	NULL
believe	NULL
,	NULL
however	NULL
,	NULL
that	NULL
the	NULL
studies	NULL
presented	NULL
here	NULL
pave	NULL
the	NULL
way	NULL
for	NULL
such	NULL
investigations	NULL
and	NULL
that	NULL
the	NULL
demonstration	NULL
of	NULL
the	NULL
direct	NULL
link	NULL
between	NULL
activation	NULL
pathways	NULL
and	NULL
vitamin	NULL
D	NULL
receptor	NULL
expression	NULL
illustrates	NULL
that	NULL
lymphocytes	NULL
are	NULL
ideal	NULL
models	NULL
for	NULL
such	NULL
studies	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
present	NULL
study	NULL
provides	NULL
evidence	NULL
to	NULL
suggest	NULL
that	NULL
activation	NULL
of	NULL
lymphocytes	NULL
leads	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
classical	NULL
vitamin	NULL
D	NULL
receptor	NULL
and	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
protein	NULL
in	NULL
lymphocytes	NULL
is	NULL
probably	NULL
regulated	NULL
at	NULL
the	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
level	NULL
by	NULL
contingent	NULL
signals	NULL
arising	NULL
from	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
,	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
pathway	NULL
,	NULL
and	NULL
perhaps	NULL
monocyte-derived	NULL
intercellular	NULL
media-tors	NULL
.	NULL

Acknowledgments-We	NULL
wish	NULL
to	NULL
thank	NULL
Dr.	NULL
W.	NULL
T.	NULL
Garvey	NULL
and	NULL
L.	NULL
Maianu	NULL
for	NULL
advice	NULL
with	NULL
the	NULL
Western	NULL
blot	NULL
method	NULL
,	NULL
Dr.	NULL
Edward	NULL
Walker	NULL
for	NULL
expert	NULL
assistance	NULL
with	NULL
the	NULL
cytofluorometric	NULL
analyses	NULL
,	NULL
and	NULL
Lindsay	NULL
O'Brien	NULL
for	NULL
typing	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Minghetti	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
and	NULL
Norman	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

2	NULL
,	NULL
3043-3053	NULL
2	NULL
.	NULL

Reichel	NULL
,	NULL
H.	NULL
,	NULL
Koeffler	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Norman	NULL
,	NULL
A.	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
New	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

320	NULL
,	NULL
980-981	NULL
3	NULL
.	NULL

Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Hustmyer	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
and	NULL
Yu	NULL
,	NULL
X.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Kidney	NULL
Int	NULL
.	NULL

38	NULL
(	NULL
Suppl	NULL
.	NULL

29	NULL
)	NULL
,	NULL
S9-816	NULL
11	NULL
.	NULL

12	NULL
.	NULL

18	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

7595	NULL
.	NULL

Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1987	NULL
)	NULL
Anticancer	NULL
Res	NULL
.	NULL

7	NULL
,	NULL
625-638	NULL
.	NULL

Kelsey	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Newland	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
and	NULL
Makin	NULL
,	NULL
J.	NULL
L.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematology	NULL
71	NULL
,	NULL
173-176	NULL
.	NULL

Haussler	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1986	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Nutr	NULL
.	NULL

6	NULL
,	NULL
527-562	NULL
.	NULL

Baker	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
McDonnell	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Hughes	NULL
,	NULL
M.	NULL
,	NULL
Crisp	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Mangelsdorf	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Haussler	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Shine	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
O'Malley	NULL
,	NULL
B.	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

85	NULL
,	NULL
3294-3298	NULL
.	NULL

McDonnell	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
Mangelsdorf	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Haussler	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
O'Malley	NULL
,	NULL
B.	NULL
W.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
285	NULL
,	NULL
1214-1217	NULL
.	NULL

Evans	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
240	NULL
,	NULL
889-895	NULL
.	NULL

Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Tusoukas	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Deftos	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1983	NULL
)	NULL
Science	NULL
221	NULL
,	NULL
1181-1183	NULL
Bhalla	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Amento	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Clemens	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
Holick	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Krane	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1983	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

57	NULL
,	NULL
1308-1310	NULL
Rossi	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
Durie	NULL
,	NULL
B.	NULL
G.	NULL
M.	NULL
,	NULL
Duperray	NULL
,	NULL
C.	NULL
,	NULL
Braich	NULL
,	NULL
T.	NULL
,	NULL
Marion	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Haussler	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Janbon	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Bataille	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

48	NULL
,	NULL
1213-1216	NULL
Nunn	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Katz	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Barker	NULL
,	NULL
S.	NULL
,	NULL
Kraher	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Hewison	NULL
,	NULL
M.	NULL
,	NULL
Hendy	NULL
,	NULL
G.	NULL
N.	NULL
,	NULL
and	NULL
O'Riordan	NULL
,	NULL
J.	NULL
L.	NULL
H.	NULL
(	NULL
1986	NULL
)	NULL
Immunology	NULL
59	NULL
,	NULL
479-484	NULL
Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Endocrinol	NULL
.	NULL

Metab	NULL
.	NULL

68	NULL
,	NULL
774-779	NULL
Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Tsoukas	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Deftos	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1986	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

186	NULL
,	NULL
2734-2740	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Werntz	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Tsoukas	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Vaughn	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1986	NULL
)	NULL
J	NULL
.	NULL

Lab	NULL
.	NULL

Clin	NULL
.	NULL

Med	NULL
.	NULL

108	NULL
,	NULL
596-600	NULL
Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Rulot	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Sobol	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Tsoukas	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1987	NULL
)	NULL
J	NULL
.	NULL

Bone	NULL
.	NULL

Min	NULL
.	NULL

Res	NULL
.	NULL

2	NULL
,	NULL
239-247	NULL
Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Deftos	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1984	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

121	NULL
,	NULL
277-283	NULL
Ravid	NULL
,	NULL
A.	NULL
,	NULL
Koren	NULL
,	NULL
R.	NULL
,	NULL
Novogrodsky	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Liberman	NULL
,	NULL
U	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1984	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

128	NULL
,	NULL
163-169	NULL
Provvedini	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Sakagami	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
(	NULL
1989	NULL
)	NULL
Endocrinology	NULL
124	NULL
,	NULL
1532-1538	NULL
Zipfel	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
Irving	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Kelly	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
1041-1048	NULL
Irving	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
and	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
(	NULL
3	NULL
)	NULL
,	NULL
1034-1040	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Science	NULL
248	NULL
,	NULL
355-361	NULL
O'Flynn	NULL
,	NULL
K.	NULL
,	NULL
Krensky	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Beverley	NULL
,	NULL
P.	NULL
C.	NULL
L.	NULL
,	NULL
Burakoff	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
and	NULL
Linch	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
313	NULL
,	NULL
686-687	NULL
Leca	NULL
,	NULL
G.	NULL
,	NULL
Boumsell	NULL
,	NULL
L.	NULL
,	NULL
Fabbi	NULL
,	NULL
M.	NULL
,	NULL
Reinherz	NULL
,	NULL
E.	NULL
L.	NULL
,	NULL
and	NULL
Kanelo-poulos	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1986	NULL
)	NULL
Scand	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
,	NULL
535	NULL
Pike	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1984	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

259	NULL
,	NULL
1167-1173	NULL
Boyum	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1968	NULL
)	NULL
Scand	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

21	NULL
,	NULL
Suppl	NULL
.	NULL

97	NULL
,	NULL
77-89	NULL
Peterson	NULL
,	NULL
G.	NULL
L.	NULL
(	NULL
1977	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

88	NULL
,	NULL
346-356	NULL
Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Sacchi	NULL
,	NULL
N.	NULL
(	NULL
1987	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
,	NULL
156-159	NULL
Tabor	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Richardson	NULL
,	NULL
C.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
4767-4771	NULL
Manolagas	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Haussler	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Deftos	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

(	NULL
1980	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

255	NULL
,	NULL
4414-4417	NULL
Merke	NULL
,	NULL
J.	NULL
,	NULL
Milde	NULL
,	NULL
P.	NULL
,	NULL
Lewicka	NULL
,	NULL
S.	NULL
,	NULL
Higel	NULL
,	NULL
U.	NULL
,	NULL
Klaus	NULL
,	NULL
G.	NULL
,	NULL
Mangelsdorf	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Haussler	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Rauterberg	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
and	NULL
Ritz	NULL
,	NULL
E.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

83	NULL
,	NULL
1903-1915	NULL
Chen	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
and	NULL
Feldman	NULL
,	NULL
D.	NULL
(	NULL
1981	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

256	NULL
,	NULL
5561-5566	NULL
Krishnan	NULL
,	NULL
A.	NULL
V.	NULL
,	NULL
and	NULL
Feldman	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
J	NULL
.	NULL

Bone	NULL
Mine	NULL
.	NULL

Res	NULL
.	NULL

5	NULL
,	NULL
Suppl	NULL
2	NULL
,	NULL
$	NULL
209	NULL
Brown	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
Deluca	NULL
,	NULL
H.	NULL
F.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265	NULL
,	NULL
10025-10029	NULL

